"","X","Column1","study","year","active_type","control_type","psy_or_med","descr_active","descr_control","instrument","instrument_name","instrument_value","rating","baseline_mean_active","baseline_sd_active","baseline_n_active","baseline_mean_control","baseline_sd_control","baseline_n_control","post_mean_active","post_sd_active","post_n_active","post_mean_control","post_sd_control","post_n_control","active_mean_change","active_sd_change","active_n_change","control_mean_change","control_sd_change","control_n_change","response_criterion","observed_responders_active","observed_responders_active_n","observed_resp_rate_active","observed_responders_control","observed_responders_control_n","observed_resp_rate_control","responders_active","responders_control","resp_rate_active","resp_rate_control","resp_rate_active_completers","resp_rate_control_completers","responders_active_30","responders_control_30","responders_active_35","responders_control_35","...49","percent_women","cuij_responders_active","cuij_responders_control","time_weeks","comorbid_mental","comorbid_mental.","country","age_group","age_m_active","age_sd_active","age_m_control","age_sd_control","age_m_overall","age_sd_overall","active_percent_women","control_percent_women","diagnosis","no_sites","Notes","comorbid_mental?","cohens_d_active","cohens_d_control","study_ID","cip_change_actv","cip_change_sd_actv","cip_change_n_actv","ae_dropouts_actv","ae_dropouts_n_actv","cip_responders_actv","cip_responders_n_actv","cip_responders_n_missing_actv","all_cause_dropouts_actv","all_cause_dropouts_n_actv","suicides_actv","suicide_n_actv","cip_change_ctrl","cip_change_sd_ctrl","cip_change_n_ctrl","ae_dropouts_ctrl","ae_dropouts_n_ctrl","cip_responders_ctrl","cip_responders_n_ctrl","cip_responders_n_missing_ctrl","all_cause_dropouts_ctrl","all_cause_dropouts_n_ctrl","suicides_ctrl","suicide_n_ctrl","change_active","change_control","scale_min","scale_max","perc_baseline_mean_active","perc_baseline_sd_active","perc_baseline_mean_control","perc_baseline_sd_control","perc_post_mean_active","perc_post_sd_active","perc_post_mean_control","perc_post_sd_control","baseline_st_error_active","baseline_st_error_control","new_study_id"
"1",NA,1,"Ackerson, 1998","1998","cbt","wl",1,"cbt","wlc","ham-d","hamd",2,"clinician",19.9,5.5,12,21,5,10,8.8,5.3,12,20.5,3.4,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,0,0.583333333333333,0,0.583333333333333,0,NA,NA,NA,NA,1,64,7,0.2,NA,"n",NA,"us",NA,15.97,1.43,15.89,0.86,NA,NA,NA,NA,"cut",NA,NA,NA,-2.05555555555555,-0.119047619047619,"Ackerson, 1998_cbt_wlc",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-11.1,-0.5,0,52,0.382692307692308,0.105769230769231,0.403846153846154,0.0961538461538462,0.169230769230769,0.101923076923077,0.394230769230769,0.0653846153846154,1.58771324027147,1.58113883008419,"Ackerson, 1998"
"2",NA,4,"Arnarson, 2009","2009","cbt","cau",1,"cbt","cau","DSM",NA,99,"clinician",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,51,NA,NA,NA,"n",NA,"eu",NA,NA,NA,NA,NA,14.5,NA,NA,NA,"sub",NA,NA,NA,NA,NA,"Arnarson, 2009_cbt_cau",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Arnarson, 2009"
"3",NA,5,"Asarnow, 2002","2002","cbt","wl",1,"cbt + family education","wlc","cdi","cdi",5,"self-report",NA,7.1,NA,NA,10.56,NA,9.54,7.1,12,12.33,10.56,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,65,NA,NA,NA,"n",NA,"us",NA,NA,NA,NA,NA,NA,NA,NA,NA,"cut",NA,NA,NA,NA,NA,"Asarnow, 2002_cbt + family education_wlc",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,54,NA,0.131481481481481,NA,0.195555555555556,0.176666666666667,0.131481481481481,0.228333333333333,0.195555555555556,NA,NA,"Asarnow, 2002"
"4",3,3,"Atkinson","2014","Duloxetine","Placebo",0,"Duloxetine","Placebo","CDRS-R","cdrs",1,"clinician",59.2,10.5,117,60.2,11.7,103,35,10.5,87,35,11.7,87,NA,NA,NA,NA,NA,NA,"50% improvement on CDRS",NA,NA,0.67,NA,NA,0.62,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,"n",NA,"USA","7 to 17",13.1,3,13.3,3.1,NA,NA,54.7,49.5,"mdd","65",NA,NA,-2.30476190476191,-2.15384615384615,"Atkinson_2014_Duloxetine_Placebo",-24.3,11.59,113,9,117,76,113,4,30,117,16,117,-24.3,11.27,103,3,103,64,103,0,16,103,15,103,NA,NA,17,113,0.439583333333333,0.109375,0.45,0.121875,0.1875,0.109375,0.1875,0.121875,0.970725343394151,1.15283525545222,"Atkinson, 2014"
"5",4,4,"Atkinson","2014","Fluoxetine","Placebo",0,"Fluoxetine","Placebo","CDRS-R","cdrs",1,"clinician",58.8,10.6,117,60.2,11.7,103,35.6,10.6,91,35,11.7,87,NA,NA,NA,NA,NA,NA,"50% improvement on CDRS",NA,NA,0.63,NA,NA,0.62,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,"n",NA,"USA","7 to 17",13.1,3.3,13.3,3.1,NA,NA,52.1,49.5,"mdd","65",NA,NA,-2.18867924528302,-2.15384615384615,"Atkinson_2014_Fluoxetine_Placebo",-23.7,11.27,113,1,117,71,113,4,26,117,18,117,-24.3,11.27,103,3,103,64,103,0,16,103,15,103,NA,NA,17,113,0.435416666666667,0.110416666666667,0.45,0.121875,0.19375,0.110416666666667,0.1875,0.121875,0.979970346664571,1.15283525545222,"Atkinson, 2014"
"6",70,70,"Atkinson","2018","Desvenlafaxine (high dose)","Placebo",0,"Desvenlafaxine (high dose)","Placebo","CDRS","cdrs",1,"clinician",58.45,9.45,121,57.28,8.94,119,34.05,9.45,NA,34.38,8.94,NA,-24.4,12.1,121,-22.9,12,119,"missing",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,"y","ADHD, self-injurious behaviour, insomnia","USA, Chile","7 to 17",12.87,3.01,13.15,2.68,NA,NA,62.81,50,"mdd","42",NA,NA,-2.58201058201058,-2.56152125279642,"Atkinson_2018_Desvenlafaxine (high dose)_Placebo",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,113,0.431770833333333,0.0984375,0.419583333333333,0.093125,0.177604166666667,0.0984375,0.181041666666667,0.093125,0.859090909090909,0.819528456343221,"Atkinson, 2018"
"7",72,72,"Atkinson","2018","Desvenlafaxine (low dose)","Placebo",0,"Desvenlafaxine (low dose)","Placebo","CDRS","cdrs",1,"clinician",58.52,9.18,122,57.28,8.94,119,34.82,9.18,NA,34.38,8.94,NA,-23.7,12.05,120,-22.9,12,119,"missing",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,"y","ADHD, self-injurious behaviour, insomnia","USA, Chile","7 to 17",13.07,2.8,13.15,2.68,NA,NA,56.56,50,"mdd","42",NA,NA,-2.58169934640523,-2.56152125279642,"Atkinson_2018_Desvenlafaxine (low dose)_Placebo",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,113,0.4325,0.095625,0.419583333333333,0.093125,0.185625,0.095625,0.181041666666667,0.093125,0.83111814867032,0.819528456343221,"Atkinson, 2018"
"8",5,5,"Berard","2006","Paroxetine","Placebo",0,"Paroxetine","Placebo","MADRS","madrs",3,"clinician",25.9,6.75,182,25.9,5.79,93,12.3,6.75,177,13.1,5.79,177,-13.6,10.91,177,-12.8,10.3,91,"50% improvement from baseline",107,177,0.604519774011299,53,91,0.582417582417582,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,"y","Anxiety disorders (specific phobia, separation anxiety disorder, panic disorder, social phobia, GAD) and ADHD","International (Belgium, Italy, Spain, UK< The Netherlands, Canada, South Africa, UAE, Argentina, Mexico)","12 to 19",15.5,1.6,15.8,1.6,NA,NA,67,67,"mdd","33",NA,NA,-2.01481481481481,-2.21070811744387,"Berard_2006_Paroxetine_Placebo",-13.6,10.91,177,20,187,107,177,10,60,187,6,187,-12.8,10.3,91,7,99,53,91,8,30,99,2,99,NA,NA,0,60,0.431666666666667,0.1125,0.431666666666667,0.0965,0.205,0.1125,0.218333333333333,0.0965,0.500343288746243,0.600395031248916,"Berard, 2006"
"9",NA,7,"Bolton, 2007","2007","ipt","other ctr",1,"ipt","creative play","Acholi Psychosocial Assessment Instrument (APAI): a local instrument","apai",99,"clinician",43.5,10.1,105,44.2,11.2,105,27.8,17.2,105,40.6,15.7,105,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,32,21,0.304761904761905,0.2,0.304761904761905,0.2,NA,NA,NA,NA,7,57,NA,NA,NA,"n",NA,"other",NA,15,1.1,14.7,1,NA,NA,NA,NA,"cut",NA,NA,NA,-1.15018315018315,-0.267657992565056,"Bolton, 2007_ipt_creative play",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-15.7,-3.6,0,105,0.414285714285714,0.0961904761904762,0.420952380952381,0.106666666666667,0.264761904761905,0.163809523809524,0.386666666666667,0.14952380952381,0.985659073678019,1.09300808170236,"Bolton, 2007"
"10",NA,6,"Bolton, 2007","2007","ipt","wl",1,"ipt","wlc","Acholi Psychosocial Assessment Instrument (APAI): a local instrument","apai",99,"clinician",43.5,10.1,105,44.2,10.8,104,27.8,17.2,105,37.3,15.9,104,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,33,22,0.314285714285714,0.211538461538462,0.314285714285714,0.211538461538462,NA,NA,NA,NA,6,57,39,14,NA,"n",NA,"other",NA,15,1.1,15.2,1.2,NA,NA,NA,NA,"cut",NA,NA,NA,-1.15018315018315,-0.51685393258427,"Bolton, 2007_ipt_wlc",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-15.7,-6.90000000000001,0,105,0.414285714285714,0.0961904761904762,0.420952380952381,0.102857142857143,0.264761904761905,0.163809523809524,0.355238095238095,0.151428571428571,0.985659073678019,1.05902712974619,"Bolton, 2007"
"11",NA,8,"Brent, 1997","1997","cbt","cau",1,"cbt","individual nondirective supportive therapy (NST)","bdi","bdi",4,"self-report",24.3,8.1,37,25.7,7.8,35,5.7,8.6,35,NA,7.8,24,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,51.9,NA,NA,NA,"n",NA,"us",NA,15.7,1.3,15.7,1.5,15.6,NA,NA,NA,"mdd",NA,NA,NA,-2.22754491017964,NA,"Brent, 1997_cbt_individual nondirective supportive therapy (NST)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-18.6,NA,0,63,0.385714285714286,0.128571428571429,0.407936507936508,0.123809523809524,0.0904761904761905,0.136507936507936,NA,0.123809523809524,1.33163179717339,1.31844063737649,"Brent, 1997"
"12",NA,9,"Brent, 1997","1997","other psy","cau",1,"systemic behavior family therapy","individual nondirective supportive therapy (NST)","bdi","bdi",4,"self-report",22.6,8.2,35,25.7,7.8,35,9.1,9.1,29,NA,7.8,24,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,78.6,NA,NA,NA,"n",NA,"us",NA,15.4,1.4,15.7,1.5,15.6,NA,NA,NA,"mdd",NA,NA,NA,-1.5606936416185,NA,"Brent, 1997_systemic behavior family therapy_individual nondirective supportive therapy (NST)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-13.5,NA,0,63,0.358730158730159,0.13015873015873,0.407936507936508,0.123809523809524,0.144444444444444,0.144444444444444,NA,0.123809523809524,1.38605297775477,1.31844063737649,"Brent, 1997"
"13",9,9,"Bristol-Myers Squibb","2002a","Nefazodone","Placebo",0,"Nefazodone","Placebo","CDRS","cdrs",1,"clinician",NA,9.32875,NA,NA,9.29964285714286,NA,NA,10.8323214285714,NA,NA,10.8732142857143,NA,-25.8,NA,NA,-22.1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,"missing","missing","USA","missing",NA,NA,NA,NA,NA,NA,NA,NA,"mdd","15",NA,NA,NA,NA,"Bristol-Myers Squibb_2002a_Nefazodone_Placebo",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,113,NA,0.0971744791666667,NA,0.0968712797619048,NA,0.112836681547619,NA,0.113262648809524,NA,NA,"Bristol-Myers Squibb, 2002a"
"14",12,12,"Bristol-Myers Squibb","2002b","Nefazodone","Placebo",0,"Nefazodone","Placebo","CDRS","cdrs",1,"clinician",61.2,9.32875,90,58.3,9.29964285714286,93,38,10.8323214285714,NA,36.7,10.8732142857143,NA,-23.2,NA,90,-21.6,NA,93,"missing",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,"missing","missing","USA","missing",NA,NA,NA,NA,NA,NA,NA,NA,"mdd","15",NA,NA,-2.30146498733415,-2.1414913957935,"Bristol-Myers Squibb_2002b_Nefazodone_Placebo",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,113,0.460416666666667,0.0971744791666667,0.430208333333333,0.0968712797619048,0.21875,0.112836681547619,0.205208333333333,0.113262648809524,0.983336590743192,0.964328042110198,"Bristol-Myers Squibb, 2002b"
"15",NA,11,"Charkhandeh, 2016","2016","cbt","other ctr",1,"cbt","Reiki","cdi","cdi",5,"self-report",29.46,5.47,65,30,5.37,63,19.94,5.59,65,26.33,5.88,63,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13,2,0.2,0.0317460317460317,0.2,0.0317460317460317,NA,NA,NA,NA,11,54,NA,NA,NA,"n",NA,"oth",NA,NA,NA,NA,NA,15.26,NA,NA,NA,"mdd",NA,NA,NA,-1.72151898734177,-0.652444444444445,"Charkhandeh, 2016_cbt_Reiki",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-9.52,-3.67,0,54,0.545555555555556,0.101296296296296,0.555555555555556,0.0994444444444444,0.369259259259259,0.103518518518519,0.487592592592593,0.108888888888889,0.67846999820297,0.676556406686517,"Charkhandeh, 2016"
"16",NA,10,"Charkhandeh, 2016","2016","cbt","wl",1,"cbt","wlc","cdi","cdi",5,"self-report",29.46,5.47,65,30.35,5.45,60,19.94,5.59,65,30.38,4.66,60,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,16,0,0.246153846153846,0,0.246153846153846,0,NA,NA,NA,NA,10,54,11,0.2,NA,"n",NA,"oth",NA,NA,NA,NA,NA,15.26,NA,NA,NA,"mdd",NA,NA,NA,-1.72151898734177,0.00593471810088973,"Charkhandeh, 2016_cbt_wlc",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-9.52,0.0299999999999976,0,54,0.545555555555556,0.101296296296296,0.562037037037037,0.100925925925926,0.369259259259259,0.103518518518519,0.562592592592593,0.0862962962962963,0.67846999820297,0.703591974561014,"Charkhandeh, 2016"
"17",NA,13,"Clarke, 1995","1995","cbt","cau",1,"cbt+cau","cau","ham-d","hamd",2,"clinician",3.55,3.2,55,3.86,3.1,70,1.87,2.5,52,2.91,4.3,68,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,20,25,0.363636363636364,0.357142857142857,0.384615384615385,0.367647058823529,NA,NA,NA,NA,13,47.3,25,28,NA,"n",NA,"us",NA,NA,NA,NA,NA,15.3,0.7,NA,NA,"sub",NA,NA,NA,-0.589473684210526,-0.256756756756757,"Clarke, 1995_cbt+cau_cau",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-1.68,-0.95,0,52,0.0682692307692308,0.0615384615384615,0.0742307692307692,0.0596153846153846,0.0359615384615385,0.0480769230769231,0.0559615384615385,0.0826923076923077,0.431487911976475,0.370520868893662,"Clarke, 1995"
"18",NA,17,"Clarke, 1999","1999","cbt","wl",1,"cbt + parenting group","wlc","ham-d","hamd",2,"clinician",15.1,6,32,14.5,5.9,27,6.7,7.1,32,7.7,7,27,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,16,18,0.5,0.666666666666667,0.5,0.666666666666667,NA,NA,NA,NA,17,71,18,7,NA,"n",NA,"us",NA,NA,NA,NA,NA,16.2,1.3,NA,NA,"mood",NA,NA,NA,-1.2824427480916,-1.05426356589147,"Clarke, 1999_cbt + parenting group_wlc",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-8.4,-6.8,0,52,0.290384615384615,0.115384615384615,0.278846153846154,0.113461538461538,0.128846153846154,0.136538461538462,0.148076923076923,0.134615384615385,1.06066017177982,1.13545552940626,"Clarke, 1999"
"19",NA,14,"Clarke, 1999","1999","cbt","wl",1,"cbt","wlc","ham-d","hamd",2,"clinician",13,5.3,37,14.5,5.9,27,4.6,4.8,37,7.7,7,27,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,24,14,0.648648648648649,0.518518518518518,0.648648648648649,0.518518518518518,NA,NA,NA,NA,14,71,24,7,NA,"n",NA,"us",NA,NA,NA,NA,NA,16.2,1.3,NA,NA,"mood",NA,NA,NA,-1.66336633663366,-1.05426356589147,"Clarke, 1999_cbt_wlc",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-8.4,-6.8,0,52,0.25,0.101923076923077,0.278846153846154,0.113461538461538,0.0884615384615385,0.0923076923076923,0.148076923076923,0.134615384615385,0.871314632718394,1.13545552940626,"Clarke, 1999"
"20",NA,21,"Clarke, 2001","2001","cbt","cau",1,"cbt + cau","cau","ham-d","hamd",2,"clinician",3.2,3.4,45,3.1,3.2,49,1.8,2.1,45,2.9,4.6,49,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,22,15,0.488888888888889,0.306122448979592,0.488888888888889,0.306122448979592,NA,NA,NA,NA,21,64,18,18,NA,"n",NA,"us",NA,14.4,1.4,14.7,1.5,NA,NA,NA,NA,"sub",NA,NA,NA,-0.509090909090909,-0.0512820512820513,"Clarke, 2001_cbt + cau_cau",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-1.4,-0.2,0,52,0.0615384615384615,0.0653846153846154,0.0596153846153846,0.0615384615384615,0.0346153846153846,0.0403846153846154,0.0557692307692308,0.0884615384615385,0.506842074899952,0.457142857142857,"Clarke, 2001"
"21",NA,24,"Clarke, 2002","2002","cbt","cau",1,"cbt + cau","cau","ham-d","hamd",2,"clinician",12,5.3,41,11.4,5,47,5.5,5.2,41,6,5.1,47,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,23,22,0.560975609756098,0.468085106382979,0.560975609756098,0.468085106382979,NA,NA,NA,NA,24,69,22,22,NA,"n",NA,"us",NA,15.2,1.3,15.3,1.3,NA,NA,NA,NA,"mood",NA,NA,NA,-1.23809523809524,-1.06930693069307,"Clarke, 2002_cbt + cau_cau",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-6.5,-5.4,0,52,0.230769230769231,0.101923076923077,0.219230769230769,0.0961538461538462,0.105769230769231,0.1,0.115384615384615,0.0980769230769231,0.827720938009612,0.729324957489473,"Clarke, 2002"
"22",NA,27,"De Cuyper, 2004","2004","cbt","wl",1,"cbt","wlc","cdi","cdi",5,"self-report",12.67,6,9,15.27,4.54,11,10.11,6.03,9,11.73,5.66,11,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,3,0.444444444444444,0.272727272727273,0.444444444444444,0.272727272727273,NA,NA,NA,NA,26,75,2,3,NA,"n",NA,"eu",NA,NA,NA,NA,NA,10,NA,NA,NA,"sub",NA,NA,NA,-0.425602660016625,-0.694117647058823,"De Cuyper, 2004_cbt_wlc",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-2.56,-3.54,0,54,0.23462962962963,0.111111111111111,0.282777777777778,0.0840740740740741,0.187222222222222,0.111666666666667,0.217222222222222,0.104814814814815,2,1.36886150438305,"De Cuyper, 2004"
"23",NA,28,"De Jonge-Heesen, 2020","2020","cbt","other ctr",1,"cbt","psychoeducation","cdi","cdi",5,"self-report",16.18,4.92,66,15.68,7.08,64,13.32,7.07,66,14.71,9.06,64,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,14,15,0.212121212121212,0.234375,0.212121212121212,0.234375,NA,NA,NA,NA,27,64,15,14,NA,"n",NA,"eu",NA,NA,NA,NA,NA,13.59,0.68,NA,NA,"cut",NA,NA,NA,-0.477064220183486,-0.120198265179678,"De Jonge-Heesen, 2020_cbt_psychoeducation",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-2.86,-0.969999999999999,0,54,0.29962962962963,0.0911111111111111,0.29037037037037,0.131111111111111,0.246666666666667,0.130925925925926,0.272407407407407,0.167777777777778,0.605610135618317,0.885,"De Jonge-Heesen, 2020"
"24",NA,29,"De Jonge-Heesen, 2020","2020","cbt","other ctr",1,"cbt","psychoeducation","cdi","cdi",5,"parent_report",20.14,5.54,66,16.78,5.86,64,18.66,6,66,15.09,6.36,64,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,10,0.0909090909090909,0.15625,0.0909090909090909,0.15625,NA,NA,NA,NA,28,64,NA,NA,NA,"n",NA,"eu",NA,NA,NA,NA,NA,13.59,0.68,NA,NA,"cut",NA,NA,NA,-0.256499133448874,-0.276595744680851,"De Jonge-Heesen, 2020_cbt_psychoeducation",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-1.48,-1.69,0,54,0.372962962962963,0.102592592592593,0.310740740740741,0.108518518518519,0.345555555555556,0.111111111111111,0.279444444444444,0.117777777777778,0.681926860025503,0.7325,"De Jonge-Heesen, 2020"
"25",NA,30,"Diamond, 2002","2002","other psy","wl",1,"abft (attachment based family therapy)","wlc","bdi","bdi",4,"self-report",23.8,7.4,16,28,7.1,16,11.8,8.8,16,18.5,11.1,16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,7,0.3125,0.4375,0.3125,0.4375,NA,NA,NA,NA,29,78,9,5,NA,"n",NA,"us",NA,NA,NA,NA,NA,14.9,1.5,NA,NA,"mdd",NA,NA,NA,-1.48148148148148,-1.04395604395604,"Diamond, 2002_abft (attachment based family therapy)_wlc",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-12,-9.5,0,63,0.377777777777778,0.117460317460317,0.444444444444444,0.112698412698413,0.187301587301587,0.13968253968254,0.293650793650794,0.176190476190476,1.85,1.775,"Diamond, 2002"
"26",NA,31,"Diamond, 2010","2010","other psy","cau",1,"Attachment-Based Family Therapy","enhanced cau","bdi-ii","bdi",4,"self-report",33,9.66,35,33,9.37,31,12.6,13.88,35,18.5,15.91,31,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,21,18,0.6,0.580645161290323,0.6,0.580645161290323,NA,NA,NA,NA,30,83,NA,NA,NA,"y",NA,"us",NA,15.11,1.41,15.29,1.83,NA,NA,NA,NA,"cut",NA,NA,"suicidality",-1.73322005097706,-1.14715189873418,"Diamond, 2010_Attachment-Based Family Therapy_enhanced cau",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-20.4,-14.5,0,63,0.523809523809524,0.153333333333333,0.523809523809524,0.148730158730159,0.2,0.22031746031746,0.293650793650794,0.252539682539683,1.63283802013549,1.68290167999088,"Diamond, 2010"
"27",76,76,"Durgam","2018","Vilazodone (15mg)","Placebo",0,"Vilazodone (15mg)","Placebo","CDRS","cdrs",1,"clinician",57.8,8.7,175,57.5,8.6,171,33.8,12,174,34,12.9,170,-22.9,11.87,174,-22.5,11.73,170,"CDRS ≥40% improvement from baseline",83,174,0.477011494252874,80,170,0.470588235294118,55,56,0.314285714285714,0.327485380116959,0.316091954022989,0.329411764705882,126,116,105,94,NA,NA,NA,NA,8,"missing","missing","USA","12 to 17",14.9,1.6,14.9,1.7,15,NA,58.9,60.2,"mdd","52",NA,NA,-2.31884057971015,-2.18604651162791,"Durgam_2018_Vilazodone (15mg)_Placebo",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,113,0.425,0.090625,0.421875,0.0895833333333333,0.175,0.125,0.177083333333333,0.134375,0.657658183036055,0.65765843709561,"Durgam, 2018"
"28",74,74,"Durgam","2018","Vilazodone (30mg)","Placebo",0,"Vilazodone (30mg)","Placebo","CDRS","cdrs",1,"clinician",56.8,8.5,180,57.5,8.6,171,32.5,11.5,180,34,12.9,170,-24.2,12.07,180,-22.5,11.73,170,"CDRS ≥40% improvement from baseline",103,180,0.572222222222222,80,170,0.470588235294118,67,55,0.372222222222222,0.321637426900585,0.372222222222222,0.323529411764706,131,115,124,113,NA,NA,NA,NA,8,"missing","missing","USA","12 to 17",14.6,1.6,14.9,1.7,15,NA,59.4,60.2,"mdd","52",NA,NA,-2.43,-2.18604651162791,"Durgam_2018_Vilazodone (30mg)_Placebo",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,113,0.414583333333333,0.0885416666666667,0.421875,0.0895833333333333,0.161458333333333,0.119791666666667,0.177083333333333,0.134375,0.63355259362494,0.65765843709561,"Durgam, 2018"
"29",13,13,"Emslie","1997","Fluoxetine","Placebo",0,"Fluoxetine","Placebo","CDRS","cdrs",1,"clinician",58.5,10.5,48,57.6,10.4,48,38.4,14.8,34,47.1,17,26,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13,4,0.270833333333333,0.0833333333333333,0.382352941176471,0.153846153846154,18,10,16,5,NA,NA,NA,NA,8,"y","Dysthymia, anxiety disordes, ADHD, oppositional/conduct disorder","USA","7 to 17",12.2,2.7,12.5,2.6,NA,NA,46,46,"mdd","1",NA,NA,-1.58893280632411,-0.766423357664234,"Emslie_1997_Fluoxetine_Placebo",-20.1,13.19,48,4,48,27,48,0,14,48,2,48,-10.5,14.84,48,1,48,16,48,0,22,48,2,48,NA,NA,17,113,0.432291666666667,0.109375,0.422916666666667,0.108333333333333,0.222916666666667,0.154166666666667,0.313541666666667,0.177083333333333,1.51554445662277,1.50111069989303,"Emslie, 1997"
"30",16,16,"Emslie","2002a","Fluoxetine","Placebo",0,"Fluoxetine","Placebo","CDRS","cdrs",1,"clinician",57.1,9.9,109,55.1,11.8,110,35.1,13.5,109,40.2,13.5,105,NA,NA,NA,NA,NA,NA,"30% improvement in CDRS",71,109,0.651376146788991,54,101,0.534653465346535,29,15,0.26605504587156,0.136363636363636,0.26605504587156,0.142857142857143,64,49,63,39,NA,NA,NA,NA,9,"y","ADHD, oppositional defiant disorder, conduct disorder","USA","8 to 17",12.7,2.46,12.69,2.67,NA,NA,49.5,49.5,"mdd","15",NA,NA,-1.88034188034188,-1.17786561264822,"Emslie_2002a_Fluoxetine_Placebo",-22,12.11,109,5,109,37,109,0,19,109,6,109,-14.9,12.74,105,9,110,17,101,9,42,110,6,110,NA,NA,17,113,0.417708333333333,0.103125,0.396875,0.122916666666667,0.188541666666667,0.140625,0.241666666666667,0.140625,0.94824802236894,1.1250858553098,"Emslie, 2002a"
"31",19,19,"Emslie","2002b","Nefazodone","Placebo",0,"Nefazodone","Placebo","CDRS","cdrs",1,"clinician",NA,9.32875,99,NA,9.29964285714286,96,NA,10.8323214285714,99,NA,10.8732142857143,96,-26.5,NA,99,-22.5,NA,96,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,"missing",NA,"USA","12 to 17",NA,NA,NA,NA,NA,NA,NA,NA,"mdd","missing",NA,NA,NA,NA,"Emslie_2002b_Nefazodone_Placebo",-26.5,14.46,99,4,99,61,99,0,27,99,0,99,-22.5,14.46,96,2,96,40,96,0,39,96,0,96,NA,NA,17,113,NA,0.0971744791666667,NA,0.0968712797619048,NA,0.112836681547619,NA,0.113262648809524,0.937574651909937,0.949140824588262,"Emslie, 2002b"
"32",22,22,"Emslie","2006","Paroxetine","Placebo",0,"Paroxetine","Placebo","CDRS","cdrs",1,"clinician",60.7,9.37,101,62.6,8.96,102,38.12,9.37,101,39.22,8.96,100,-22.58,14.77,101,-23.38,16,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,"y","adhd","USA + Canada","7 to 17",11.9,3,12.1,2.95,12,2.97,46.8,46.8,"mdd","40",NA,NA,-2.40981856990395,-2.609375,"Emslie_2006_Paroxetine_Placebo",-22.58,14.77,101,9,104,49,101,3,34,104,2,104,-23.38,16,100,2,102,46,100,2,23,102,1,102,NA,NA,17,113,0.455208333333333,0.0976041666666667,0.475,0.0933333333333333,0.22,0.0976041666666667,0.231458333333333,0.0933333333333333,0.93234984722676,0.8871721985071,"Emslie, 2006"
"33",24,24,"Emslie","2007a","Venlafaxine","Placebo",0,"Venlafaxine","Placebo","CDRS","cdrs",1,"clinician",54.4,13.19,80,54.4,12.82,85,36.3,13.19,68,38.3,12.82,73,NA,NA,NA,NA,NA,NA,"35% improvement from baseline score",43,68,0.632352941176471,37,73,0.506849315068493,22,13,0.275,0.152941176470588,0.323529411764706,0.178082191780822,44,36,27,24,NA,NA,NA,NA,8,"n",NA,"USA","7 to 17",NA,2.6,NA,2.6,NA,NA,NA,NA,"mdd","50",NA,NA,-1.37225170583776,-1.25585023400936,"Emslie_2007a_Venlafaxine_Placebo",-18.1,12.86,68,NA,NA,26,65,NA,NA,NA,3,86,-16.1,12.9,73,NA,NA,28,70,NA,NA,NA,0,81,NA,NA,17,113,0.389583333333333,0.137395833333333,0.389583333333333,0.133541666666667,0.201041666666667,0.137395833333333,0.221875,0.133541666666667,1.47468683116111,1.39052423461759,"Emslie, 2007a"
"34",25,25,"Emslie","2007b","Venlafaxine","Placebo",0,"Venlafaxine","Placebo","CDRS","cdrs",1,"clinician",57.3,13.06,102,57.3,13.43,94,32.7,13.06,101,34.5,13.43,92,NA,NA,NA,NA,NA,NA,"35% improvement from baseline score",77,101,0.762376237623762,62,92,0.673913043478261,30,29,0.294117647058824,0.308510638297872,0.297029702970297,0.315217391304348,70,67,72,51,NA,NA,NA,NA,8,"n",NA,"USA","7 to 17",NA,2.6,NA,2.6,NA,NA,NA,NA,"mdd","50",NA,NA,-1.88361408882083,-1.69769173492182,"Emslie_2007b_Venlafaxine_Placebo",-24.3,12.66,101,NA,NA,59,101,NA,NA,NA,5,95,-22.6,13.52,92,NA,NA,51,92,NA,NA,NA,0,103,NA,NA,17,113,0.419791666666667,0.136041666666667,0.419791666666667,0.139895833333333,0.163541666666667,0.136041666666667,0.182291666666667,0.139895833333333,1.29313269112754,1.38519873372556,"Emslie, 2007b"
"35",28,28,"Emslie","2009","Escitalopram","Placebo",0,"Escitalopram","Placebo","CDRS","cdrs",1,"clinician",57.6,8.19,154,56,8.27,157,35.5,8.19,NA,37.2,8.27,NA,-22.1,15.14,154,-18.8,15.91,157,"40% improvement from baseline score",91,154,0.590909090909091,76,157,0.484076433121019,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,"y","ADHD, enuresis, GAD","USA","12 to 17",14.7,1.6,14.5,1.5,NA,NA,59.4,58.6,"mdd","40",NA,NA,-2.6984126984127,-2.273276904474,"Emslie_2009_Escitalopram_Placebo",-22.1,15.14,154,4,158,99,154,4,32,158,14,158,-18.8,15.91,157,1,158,83,157,1,25,158,15,158,NA,NA,17,113,0.422916666666667,0.0853125,0.40625,0.0861458333333333,0.192708333333333,0.0853125,0.210416666666667,0.0861458333333333,0.659969007536786,0.660017853454724,"Emslie, 2009"
"36",30,30,"Emslie","2014","Duloxetine","Placebo",0,"Duloxetine","Placebo","CDRS","cdrs",1,"clinician",59.3,10.9,108,58.2,9.4,122,35,10.9,105,37.4,9.4,117,-23.9,NA,105,-21.6,NA,117,"50% improvement from baseline scores",NA,NA,0.69,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,"n",NA,"USA, Mexico, Canada, Argentina","7 to 17",12.9,2.9,13.1,2.9,NA,NA,55.6,56.6,"mdd","60",NA,NA,-2.22935779816514,-2.21276595744681,"Emslie_2014_Duloxetine_Placebo",-24.26,13.53,219,19,224,151,219,5,68,224,28,224,-21.6,13.74,117,4,122,70,117,5,37,122,17,122,NA,NA,17,113,0.440625,0.113541666666667,0.429166666666667,0.0979166666666667,0.1875,0.113541666666667,0.2125,0.0979166666666667,1.04885298902782,0.851036012799674,"Emslie, 2014"
"37",31,31,"Emslie","2014","Duloxetine","Placebo",0,"Duloxetine","Placebo","CDRS","cdrs",1,"clinician",59.8,11,116,58.2,9.4,122,34.4,11,114,37.4,9.4,117,-24.6,NA,114,-21.6,NA,117,"50% improvement from baseline scores",NA,NA,0.69,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,"n",NA,"USA, Mexico, Canada, Argentina","7 to 17",12.9,2.9,13.1,2.9,NA,NA,40.5,56.6,"mdd","60",NA,NA,-2.30909090909091,-2.21276595744681,"Emslie_2014_Duloxetine_Placebo",-24.26,13.53,219,19,224,151,219,5,68,224,28,224,-21.6,13.74,117,4,122,70,117,5,37,122,17,122,NA,NA,17,113,0.445833333333333,0.114583333333333,0.429166666666667,0.0979166666666667,0.18125,0.114583333333333,0.2125,0.0979166666666667,1.02132435997379,0.851036012799674,"Emslie, 2014"
"38",32,32,"Emslie","2014","Fluoxetine","Placebo",0,"Fluoxetine","Placebo","CDRS","cdrs",1,"clinician",57.9,10.1,117,58.2,9.4,122,36.4,10.1,112,37.4,9.4,117,-22.6,NA,112,-21.6,NA,117,"50% improvement from baseline scores",NA,NA,0.61,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,"n",NA,"USA, Mexico, Canada, Argentina","7 to 17",13,3.2,13.1,2.9,NA,NA,52.1,56.6,"mdd","60",NA,NA,-2.12871287128713,-2.21276595744681,"Emslie_2014_Fluoxetine_Placebo",-22.6,13.44,112,6,117,68,112,5,33,117,15,117,-21.6,13.74,117,4,122,70,117,5,37,122,17,122,NA,NA,17,113,0.426041666666667,0.105208333333333,0.429166666666667,0.0979166666666667,0.202083333333333,0.105208333333333,0.2125,0.0979166666666667,0.933745330312469,0.851036012799674,"Emslie, 2014"
"39",NA,34,"Esposito-Smythers, 2019","2019","cbt","cau",1,"cbt","cau","cdi","cdi",5,"self-report",27,8.7,74,26.3,9.8,73,13.2,9.3,64,13.8,9.2,62,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,31,33,0.418918918918919,0.452054794520548,0.484375,0.532258064516129,NA,NA,NA,NA,31,76,25,21,NA,"y",NA,"us",NA,NA,NA,NA,NA,14.91,NA,NA,NA,"mood",NA,NA,"at least one of the following co-occurring riskfactors: a SA prior to the index admission, NSSI, or a substanceuse disorder",-1.53333333333333,-1.31578947368421,"Esposito-Smythers, 2019_cbt_cau",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-13.8,-12.5,0,54,0.5,0.161111111111111,0.487037037037037,0.181481481481481,0.244444444444444,0.172222222222222,0.255555555555556,0.17037037037037,1.01135445707123,1.14700324252208,"Esposito-Smythers, 2019"
"40",33,33,"Findling","2009","Fluoxetine","Placebo",0,"Fluoxetine","Placebo","CDRS","cdrs",1,"clinician",53,9.84,18,53.94,9.84,16,34.6,13.66,18,31.31,13.68,16,-18.4,12.47,18,-22.63,12.48,16,"30% improvement from baseline",NA,NA,0.72,NA,16,0.81,5,9,0.277777777777778,0.5625,0.277777777777778,0.5625,10,11,12,9,NA,NA,NA,NA,8,"y","Substance-related disorder, ADHD, PTSD, conduct disorder","USA","12 to 17",16.55,1.11,16.35,1.08,16.46,1.08,22,6,"mdd","1",NA,NA,-1.56595744680851,-1.92431972789116,"Findling_2009_Fluoxetine_Placebo",-18.4,12.47,18,0,18,9,18,0,6,18,NA,NA,-22.63,12.48,16,0,16,6,16,0,3,16,NA,NA,NA,NA,17,113,0.375,0.1025,0.384791666666667,0.1025,0.183333333333333,0.142291666666667,0.1490625,0.1425,2.31931024229188,2.46,"Findling, 2009"
"41",86,86,"Findling","2020","Fluoxetine","Placebo",0,"Fluoxetine","Placebo","CDRS","cdrs",1,"clinician",58.1,8.3,97,57.7,9.2,182,34.7,12.8,97,37.8,13.7,182,-22.71,12.8,97,-20.3,1,182,"CDRS ≥40% improvement from baseline",46,84,0.547619047619048,67,155,0.432258064516129,35,41,0.360824742268041,0.225274725274725,0.360824742268041,0.225274725274725,69,96,46,98,NA,NA,NA,NA,8,"y","Learning disorders, ADHD, Communication disorders, oppositional defiant disorder, anxiety disorders","USA, Canada","7 to 17",13.2,2.8,13,2.9,13,NA,52.6,57,"mdd","60",NA,NA,-2.21800947867299,-1.73799126637555,"Findling_2020_Fluoxetine_Placebo",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,113,0.428125,0.0864583333333333,0.423958333333333,0.0958333333333333,0.184375,0.133333333333333,0.216666666666667,0.142708333333333,0.842737317060904,0.681949371328213,"Findling, 2020"
"42",84,84,"Findling","2020","Vilazodone","Placebo",0,"Vilazodone","Placebo","CDRS","cdrs",1,"clinician",58.5,9.4,186,57.7,9.2,182,37.2,14.2,186,37.8,13.7,182,-20.7,13.6,186,-20.3,1,182,"CDRS ≥40% improvement from baseline",81,158,0.512658227848101,67,155,0.432258064516129,53,48,0.28494623655914,0.263736263736264,0.28494623655914,0.263736263736264,127,106,102,87,NA,NA,NA,NA,8,"y","Learning disorders, ADHD, Communication disorders, oppositional defiant disorder, anxiety disorders","USA, Canada","7 to 17",13,2.9,13,2.9,13,NA,67.4,57,"mdd","60",NA,NA,-1.80508474576271,-1.73799126637555,"Findling_2020_Vilazodone_Placebo",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,113,0.432291666666667,0.0979166666666667,0.423958333333333,0.0958333333333333,0.210416666666667,0.147916666666667,0.216666666666667,0.142708333333333,0.689241440600361,0.681949371328213,"Findling, 2020"
"43",98,98,"Forest","2020","Fluoxetine","Placebo",0,"Fluoxetine","Placebo","CDRS","cdrs",1,"clinician",61.5,9.32875,134,61.1,9.29964285714286,140,37.13,10.8323214285714,112,38.2,10.8732142857143,118,-24.37,11.85,112,-22.9,11.84,118,"missing",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,"n",NA,"USA, Puerto Rico","14 to 17",14.7,1.67,14.3,1.59,14.7,1.67,62.7,69.5,"mdd","49",NA,NA,-2.41753024747126,-2.27037745202181,"Forest_2020_Fluoxetine_Placebo",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,113,0.463541666666667,0.0971744791666667,0.459375,0.0968712797619048,0.2096875,0.112836681547619,0.220833333333333,0.113262648809524,0.805881257514211,0.785963272816995,"Forest, 2020"
"44",96,96,"Forest","2020","Levomilnacipran (40mg)","Placebo",0,"Levomilnacipran (40mg)","Placebo","CDRS","cdrs",1,"clinician",61.8,9.32875,134,61.1,9.29964285714286,140,38.52,10.8323214285714,115,38.2,10.8732142857143,118,-23.28,11.9,115,-22.9,11.84,118,"missing",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,"n",NA,"USA, Puerto Rico","12 to 17",14.8,1.62,14.3,1.59,14.7,1.67,70.1,69.5,"mdd","49",NA,NA,-2.30940107349737,-2.27037745202181,"Forest_2020_Levomilnacipran (40mg)_Placebo",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,113,0.466666666666667,0.0971744791666667,0.459375,0.0968712797619048,0.224166666666667,0.112836681547619,0.220833333333333,0.113262648809524,0.805881257514211,0.785963272816995,"Forest, 2020"
"45",97,97,"Forest","2020","Levomilnacipran (80mg)","Placebo",0,"Levomilnacipran (80mg)","Placebo","CDRS","cdrs",1,"clinician",59.4,9.32875,138,61.1,9.29964285714286,140,36.76,10.8323214285714,110,38.2,10.8732142857143,118,-22.64,11.74,110,-22.9,11.84,118,"missing",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,"n",NA,"USA, Puerto Rico","13 to 17",14.8,1.75,14.3,1.59,14.7,1.67,63,69.5,"mdd","49",NA,NA,-2.2459123841916,-2.27037745202181,"Forest_2020_Levomilnacipran (80mg)_Placebo",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,113,0.441666666666667,0.0971744791666667,0.459375,0.0968712797619048,0.205833333333333,0.112836681547619,0.220833333333333,0.113262648809524,0.794115936131568,0.785963272816995,"Forest, 2020"
"46",NA,35,"Fristad, 2019","2019","cbt","other ctr",1,"cbt + placebo","placebo","cdrs-r","cdrs",1,"clinician",42,9,19,44,13,18,30,9,18,31,11,18,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,3,0.105263157894737,0.166666666666667,0.111111111111111,0.166666666666667,NA,NA,NA,NA,32,43.1,NA,NA,NA,"n",NA,"us",NA,11.7,2.1,11.1,2.4,11.6,2.1,NA,NA,"mood",NA,NA,NA,-1.33333333333333,-1.08333333333333,"Fristad, 2019_cbt + placebo_placebo",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-12,-13,17,113,0.260416666666667,0.09375,0.28125,0.135416666666667,0.135416666666667,0.09375,0.145833333333333,0.114583333333333,2.06474160483506,3.06412938514171,"Fristad, 2019"
"47",37,37,"Geller","1990","Nortriptyline","Placebo",0,"Nortriptyline","Placebo","CDRS","cdrs",1,"clinician",51.3,4.4,12,52.4,3.7,19,34.7,7.8,12,37.8,9.1,19,NA,NA,NA,NA,NA,NA,"CDRS score of ≤25",1,12,0.0833333333333333,4,19,0.210526315789474,2,1,0.166666666666667,0.0526315789473684,0.166666666666667,0.0526315789473684,7,9,5,4,NA,NA,NA,NA,8,"y","Melancholia, separation anxiety, antisocial behaviour","USA","12 to 17",14,1.7,14.4,1.6,14.3,1.5,75,42.1,"mdd","missing",NA,NA,-2.72131147540984,-2.28125,"Geller_1990_Nortriptyline_Placebo",-16.6,6.77,12,NA,NA,1,12,0,NA,NA,NA,NA,-13.6,7.93,19,NA,NA,4,19,0,NA,NA,NA,NA,NA,NA,17,113,0.357291666666667,0.0458333333333333,0.36875,0.0385416666666667,0.184375,0.08125,0.216666666666667,0.0947916666666667,1.27017059221718,0.848838215321079,"Geller, 1990"
"48",38,38,"Geller","1992","Nortriptyline","Placebo",0,"Nortriptyline","Placebo","CDRS","cdrs",1,"clinician",49.9,4.2,26,49.6,4.6,24,32.9,11.4,26,32,9.8,24,NA,NA,NA,NA,NA,NA,"CDRS score of ≤20",8,26,0.307692307692308,4,24,0.166666666666667,6,3,0.230769230769231,0.125,0.230769230769231,0.125,17,13,14,9,NA,NA,NA,NA,8,"n",NA,"USA","6 to 12",9.7,1.6,9.7,1.7,9.7,1.6,26.9,33.3,"mdd","missing",NA,NA,-2.17948717948718,-2.44444444444444,"Geller_1992_Nortriptyline_Placebo",-17,9.99,26,NA,NA,8,26,4,4,30,NA,NA,-17.6,8.49,24,NA,NA,4,24,6,6,30,NA,NA,NA,NA,17,113,0.342708333333333,0.04375,0.339583333333333,0.0479166666666667,0.165625,0.11875,0.15625,0.102083333333333,0.823687767580373,0.938971068066885,"Geller, 1992"
"49",NA,36,"Gillham, 2006","2006","cbt","cau",1,"cbt","cau","cdi","cdi",5,"self-report",13.19,7.81,147,12.57,7.17,124,11.55,8.21,112,11.37,7.9,104,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,29,23,0.197278911564626,0.185483870967742,0.258928571428571,0.221153846153846,NA,NA,NA,NA,33,53,31,27,NA,"n",NA,"us",NA,NA,NA,NA,NA,11.5,NA,NA,NA,"sub",NA,NA,NA,-0.204744069912609,-0.159256801592568,"Gillham, 2006_cbt_cau",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-1.64,-1.2,0,54,0.244259259259259,0.14462962962963,0.232777777777778,0.132777777777778,0.213888888888889,0.152037037037037,0.210555555555556,0.146296296296296,0.644157943195854,0.643885007765988,"Gillham, 2006"
"50",40,40,"Hughes","1990","Imipramine","Placebo",0,"Imipramine","Placebo","CDRS","cdrs",1,"clinician",NA,9.32875,NA,NA,9.29964285714286,NA,NA,10.8323214285714,NA,NA,10.8732142857143,NA,NA,NA,NA,NA,NA,NA,"50% reduction in CDRS",4,7,0.571428571428571,1,5,0.2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,"y","Anxiety-related disorders (Group1) and Conduct or oppositional disorders (group2)",NA,"6 to 12",NA,NA,NA,NA,NA,NA,NA,NA,"mdd","missing",NA,NA,NA,NA,"Hughes_1990_Imipramine_Placebo",NA,NA,NA,NA,NA,6,13,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,14,0,NA,NA,NA,NA,NA,NA,17,113,NA,0.0971744791666667,NA,0.0968712797619048,NA,0.112836681547619,NA,0.113262648809524,NA,NA,"Hughes, 1990"
"51",41,41,"Hughes","1990","Imipramine","Placebo",0,"Imipramine","Placebo","CDRS","cdrs",1,"clinician",NA,9.32875,NA,NA,9.29964285714286,NA,NA,10.8323214285714,NA,NA,10.8732142857143,NA,NA,NA,NA,NA,NA,NA,"50% reduction in CDRS",2,6,0.333333333333333,6,9,0.666666666666667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,"y","Anxiety-related disorders (Group1) and Conduct or oppositional disorders (group2)",NA,"6 to 12",NA,NA,NA,NA,NA,NA,NA,NA,"mdd","missing",NA,NA,NA,NA,"Hughes_1990_Imipramine_Placebo",NA,NA,NA,NA,NA,6,13,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,14,0,NA,NA,NA,NA,NA,NA,17,113,NA,0.0971744791666667,NA,0.0968712797619048,NA,0.112836681547619,NA,0.113262648809524,NA,NA,"Hughes, 1990"
"52",NA,37,"Idsoe, 2019","2019","cbt","cau",1,"cbt","cau","ces-d","ces_d",11,"self-report",33.08,9.97,133,32.01,9.75,95,26.85,11.82,133,29.55,10.77,95,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26,13,0.195488721804511,0.136842105263158,0.195488721804511,0.136842105263158,NA,NA,NA,NA,34,88,25,10,NA,"n",NA,"eu",NA,NA,NA,NA,NA,16.7,1.14,NA,NA,"cut",NA,NA,NA,-0.571821936668196,-0.239766081871345,"Idsoe, 2019_cbt_cau",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-6.23,-2.46,0,60,0.551333333333333,0.166166666666667,0.5335,0.1625,0.4475,0.197,0.4925,0.1795,0.864508639615548,1.00032889328303,"Idsoe, 2019"
"53",NA,38,"Israel, 2013","2013","other psy","cau",1,"abft (attachment based family therapy)","cau","ham-d","hamd",2,"clinician",20.6,4.6,11,19.7,5.5,9,12.5,7.2,11,19.4,5.2,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,1,0.363636363636364,0.111111111111111,0.363636363636364,0.111111111111111,NA,NA,NA,NA,35,55,4,0.2,NA,"n",NA,"eu",NA,NA,NA,NA,NA,15.6,0.99,NA,NA,"mdd",NA,NA,NA,-1.3728813559322,-0.0560747663551403,"Israel, 2013_abft (attachment based family therapy)_cau",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-8.1,-0.300000000000001,0,52,0.396153846153846,0.0884615384615385,0.378846153846154,0.105769230769231,0.240384615384615,0.138461538461538,0.373076923076923,0.1,1.38695218505771,1.83333333333333,"Israel, 2013"
"54",NA,46,"Kahn, 1990","1990","cbt","other ctr",1,"cbt","Relaxation","cdi","cdi",5,"self-report",31.11,9.58,17,26.94,10.83,17,7.29,66.03,17,12.88,10.71,17,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,7,0.588235294117647,0.411764705882353,0.588235294117647,0.411764705882353,NA,NA,NA,NA,43,52,NA,NA,NA,"n",NA,"us",NA,NA,NA,NA,NA,12.1,NA,NA,NA,"mdd",NA,NA,NA,-0.630075386853591,-1.30547818012999,"Kahn, 1990_cbt_Relaxation",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-23.82,-14.06,0,54,0.576111111111111,0.177407407407407,0.498888888888889,0.200555555555556,0.135,1.22277777777778,0.238518518518519,0.198333333333333,2.32349128784807,2.62666081914349,"Kahn, 1990"
"55",NA,40,"Kahn, 1990","1990","cbt","wl",1,"cbt","wlc","cdi","cdi",5,"self-report",31.11,9.58,17,28.06,9.75,17,7.29,66.03,17,26.94,15.41,17,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11,1,0.647058823529412,0.0588235294117647,0.647058823529412,0.0588235294117647,NA,NA,NA,NA,37,52,11,3,NA,"n",NA,"us",NA,NA,NA,NA,NA,12.1,NA,NA,NA,"mdd",NA,NA,NA,-0.630075386853591,-0.0890302066772653,"Kahn, 1990_cbt_wlc",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-23.82,-1.12,0,54,0.576111111111111,0.177407407407407,0.51962962962963,0.180555555555556,0.135,1.22277777777778,0.498888888888889,0.28537037037037,2.32349128784807,2.36472234410425,"Kahn, 1990"
"56",NA,43,"Kahn, 1990","1990","other psy","wl",1,"self-modeling","wlc","cdi","cdi",5,"self-report",27.18,7.84,17,28.06,9.75,17,13.58,7.38,17,26.94,15.41,17,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,7,0.352941176470588,0.411764705882353,0.352941176470588,0.411764705882353,NA,NA,NA,NA,40,52,8,3,NA,"n",NA,"us",NA,NA,NA,NA,NA,12.1,NA,NA,NA,"mdd",NA,NA,NA,-1.78712220762155,-0.0890302066772653,"Kahn, 1990_self-modeling_wlc",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-13.6,-1.12,0,54,0.503333333333333,0.145185185185185,0.51962962962963,0.180555555555556,0.251481481481481,0.136666666666667,0.498888888888889,0.28537037037037,1.90147930028485,2.36472234410425,"Kahn, 1990"
"57",45,45,"Keller","2001","Imipramine","Placebo",0,"Imipramine","Placebo","HAM-D","hamd",2,"clinician",18.11,4.19,95,18.97,4.1,87,9.2,7.85,94,9.88,7.74,87,NA,NA,NA,NA,NA,NA,"50% improvement from baseline",55,94,0.585106382978723,48,87,0.551724137931034,46,38,0.484210526315789,0.436781609195402,0.48936170212766,0.436781609195402,64,60,60,67,NA,NA,NA,NA,8,"y","Anxiety disorders (e.g. separation anxiety, social anxiety disorder) and externalising disorders","USA + Canada","12 to 18",14.9,1.6,15.1,1.6,NA,NA,58.9,65.5,"mdd","12",NA,NA,-1.48006644518272,-1.53547297297297,"Keller_2001_Imipramine_Placebo",-8.91,6.8,94,30,95,49,94,1,38,95,2,95,-9.09,6.71,87,6,87,42,87,0,21,87,1,87,NA,NA,0,52,0.348269230769231,0.0805769230769231,0.364807692307692,0.0788461538461538,0.176923076923077,0.150961538461538,0.19,0.148846153846154,0.42988492952368,0.439566139283496,"Keller, 2001"
"58",42,42,"Keller","2001","Paroxetine","Placebo",0,"Paroxetine","Placebo","HAM-D","hamd",2,"clinician",18.98,4.15,93,18.97,4.1,87,8.24,7.68,90,9.88,7.74,87,NA,NA,NA,NA,NA,NA,"50% improvement from baseline",60,90,0.666666666666667,48,87,0.551724137931034,55,46,0.591397849462366,0.528735632183908,0.611111111111111,0.528735632183908,67,58,57,49,NA,NA,NA,NA,8,"y","Anxiety disorders (e.g. separation anxiety, social anxiety disorder) and externalising disorders","USA + Canada","12 to 18",14.8,1.6,15.1,1.6,NA,NA,62.4,65.5,"mdd","12",NA,NA,-1.81572273879966,-1.53547297297297,"Keller_2001_Paroxetine_Placebo",-10.74,6.66,90,9,93,59,90,3,26,93,4,93,-9.09,6.71,87,6,87,42,87,0,21,87,1,87,NA,NA,0,52,0.365,0.0798076923076923,0.364807692307692,0.0788461538461538,0.158461538461538,0.147692307692308,0.19,0.148846153846154,0.430334953313127,0.439566139283496,"Keller, 2001"
"59",48,48,"Klein","1998","Desipramine","Placebo",0,"Desipramine","Placebo","HAM-D","hamd",2,"clinician",21.44,3.7,23,21.33,5.2,22,10.23,2.1,18,14.61,2.1,18,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,0,0.347826086956522,0,0.444444444444444,0,18,10,18,9,NA,NA,NA,NA,6,"y","Anxiety disorders and behaviour disorders","USA","13 to 18",NA,NA,NA,NA,15.66,1.43,67,67,"mdd","missing",NA,NA,-3.86551724137931,-1.84109589041096,"Klein_1998_Desipramine_Placebo",-10.61,3.21,18,1,23,12,18,5,5,23,NA,NA,-6.72,4.53,18,2,22,9,18,4,4,22,NA,NA,NA,NA,0,52,0.412307692307692,0.0711538461538462,0.410192307692308,0.1,0.196730769230769,0.0403846153846154,0.280961538461538,0.0403846153846154,0.771503332011177,1.10864372504917,"Klein, 1998"
"60",51,51,"Kutcher","1994","Desipramine","Placebo",0,"Desipramine","Placebo","HAM-D","hamd",2,"clinician",22.63,5.17,30,23.77,5.31,30,12.68,8.68,17,13.42,8.43,25,NA,NA,NA,NA,NA,NA,"50% improvement from baseline",NA,NA,0.48,NA,NA,0.35,9,7,0.3,0.233333333333333,0.529411764705882,0.28,11,14,14,16,NA,NA,NA,NA,6,"n",NA,"Canada","15 to 20",NA,NA,NA,NA,17.8,NA,70,70,"mdd","missing",NA,NA,-1.43682310469314,-1.50655021834061,"Kutcher_1994_Desipramine_Placebo",-9.95,7.56,17,9,30,8,17,13,13,30,NA,NA,-10.35,7.38,25,1,30,9,25,5,5,30,NA,NA,NA,NA,0,52,0.435192307692308,0.0994230769230769,0.457115384615385,0.102115384615385,0.243846153846154,0.166923076923077,0.258076923076923,0.162115384615385,0.943908540767236,0.969468926784144,"Kutcher, 1994"
"61",52,52,"Kutcher","1994","Desipramine","Placebo",0,"Desipramine","Placebo","HAM-D","hamd",2,"clinician",22.63,5.17,30,23.77,5.31,30,12.68,8.68,17,13.42,8.43,25,NA,NA,NA,NA,NA,NA,"Dichotomous outcome variable (well/ill). Final HAM-D score of 7 or less indicated well",NA,NA,0.28,NA,NA,NA,7,13,0.233333333333333,0.433333333333333,0.411764705882353,0.52,10,18,7,13,NA,NA,NA,NA,6,"n",NA,"Canada","15 to 20",NA,NA,NA,NA,17.8,NA,70,70,"mdd","missing",NA,NA,-1.43682310469314,-1.50655021834061,"Kutcher_1994_Desipramine_Placebo",-9.95,7.56,17,9,30,8,17,13,13,30,NA,NA,-10.35,7.38,25,1,30,9,25,5,5,30,NA,NA,NA,NA,0,52,0.435192307692308,0.0994230769230769,0.457115384615385,0.102115384615385,0.243846153846154,0.166923076923077,0.258076923076923,0.162115384615385,0.943908540767236,0.969468926784144,"Kutcher, 1994"
"62",55,55,"Kye","1996","Amitriptyline","Placebo",0,"Amitriptyline","Placebo","HAM-D","hamd",2,"clinician",12,4.5,18,13.2,4.1,13,8,4.9,12,8.8,4.5,10,NA,NA,NA,NA,NA,NA,"50% improvement",13,18,0.722222222222222,11,13,0.846153846153846,7,4,0.388888888888889,0.307692307692308,0.583333333333333,0.4,7,9,9,4,NA,NA,NA,NA,8,"n",NA,"USA","12 to 17",14.6,1.8,15.1,2.1,NA,NA,27.7,30.8,"mdd","missing",NA,NA,-0.851063829787234,-1.02325581395349,"Kye_1996_Amitriptyline_Placebo",-4,4.71,18,1,18,13,18,0,6,18,NA,NA,-4.4,4.31,13,1,13,11,13,0,3,13,NA,NA,NA,NA,0,52,0.230769230769231,0.0865384615384615,0.253846153846154,0.0788461538461538,0.153846153846154,0.0942307692307692,0.169230769230769,0.0865384615384615,1.06066017177982,1.13713540226172,"Kye, 1996"
"63",90,90,"Le Noury","2015","Imipramine","Placebo",0,"Imipramine","Placebo","HAM-D","hamd",2,"clinician",18.1,4.19,95,19,4.1,87,9.1,4.19,NA,9.9,4.1,NA,-9,7.85,94,-9.1,0.83,87,"HAM-D score ≤8 or ≥50% improvement",55,94,0.585106382978723,48,87,0.551724137931034,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,"y","Anxiety disorder, Oppositional Defiant Disorder, Conduct Disorder, ADHD","USA, Canada","12 to 18",14.9,1.6,15.1,1.6,NA,NA,69.6,52.6,"mdd","12",NA,NA,-2.14797136038186,-2.21951219512195,"Le Noury_2015_Imipramine_Placebo",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,52,0.348076923076923,0.0805769230769231,0.365384615384615,0.0788461538461538,0.175,0.0805769230769231,0.190384615384615,0.0788461538461538,0.42988492952368,0.439566139283496,"Le Noury, 2015"
"64",88,88,"Le Noury","2015","Paroxetine","Placebo",0,"Paroxetine","Placebo","HAM-D","hamd",2,"clinician",18.9,4.24,93,19,4.1,87,8.2,4.24,NA,9.9,4.1,NA,-10.7,7.68,90,-9.1,0.83,87,"HAM-D score <8 or ≥50% improvement",60,90,0.666666666666667,48,87,0.551724137931034,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,"y","Anxiety disorder, Oppositional Defiant Disorder, Conduct Disorder, ADHD","USA, Canada","12 to 18",14.8,1.6,15.1,1.6,NA,NA,60.3,52.6,"mdd","12",NA,NA,-2.52358490566038,-2.21951219512195,"Le Noury_2015_Paroxetine_Placebo",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,52,0.363461538461538,0.0815384615384615,0.365384615384615,0.0788461538461538,0.157692307692308,0.0815384615384615,0.190384615384615,0.0788461538461538,0.4396675185657,0.439566139283496,"Le Noury, 2015"
"65",NA,55,"Lewinsohn, 1990","1990","cbt","wl",1,"cwb adolescents + parents","wlc","bdi","bdi",4,"self-report",21.26,11.35,19,23.84,11.43,19,6.47,8.53,19,20.47,10.28,19,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,3,0.631578947368421,0.157894736842105,0.631578947368421,0.157894736842105,NA,NA,NA,NA,50,65,13,4,NA,"n",NA,"us",NA,16.26,1.17,16.28,1.17,NA,NA,NA,NA,"mood",NA,NA,NA,-1.48792756539235,-0.310456011054814,"Lewinsohn, 1990_cwb adolescents + parents_wlc",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-14.79,-3.37,0,63,0.337460317460317,0.18015873015873,0.378412698412698,0.181428571428571,0.102698412698413,0.135396825396825,0.324920634920635,0.163174603174603,2.60386857943088,2.62222183814052,"Lewinsohn, 1990"
"66",NA,52,"Lewinsohn, 1990","1990","cbt","wl",1,"cwb adolescents only","wlc","bdi","bdi",4,"self-report",21.67,11.34,21,23.84,11.43,19,10,11.91,21,20.47,10.28,19,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,2,0.428571428571429,0.105263157894737,0.428571428571429,0.105263157894737,NA,NA,NA,NA,47,61,11,4,NA,"n",NA,"us",NA,16.15,0.98,16.28,1.17,NA,NA,NA,NA,"mood",NA,NA,NA,-1.00387096774194,-0.310456011054814,"Lewinsohn, 1990_cwb adolescents only_wlc",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-11.67,-3.37,0,63,0.343968253968254,0.18,0.378412698412698,0.181428571428571,0.158730158730159,0.189047619047619,0.324920634920635,0.163174603174603,2.47459087527615,2.62222183814052,"Lewinsohn, 1990"
"67",NA,58,"Liddle, 1990","1990","cbt","other ctr",1,"cbt (social competence training)","attention placebo (drama)","cdi","cdi",5,"self-report",21,4.45,11,22.3,4.24,10,14.45,6.74,11,19.3,6.93,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,1,0.272727272727273,0.1,0.272727272727273,0.1,NA,NA,NA,NA,53,32,NA,NA,NA,"n",NA,"au",NA,NA,NA,NA,NA,9.2,1.15,NA,NA,"cut",NA,NA,NA,-1.17068811438785,-0.53715308863026,"Liddle, 1990_cbt (social competence training)_attention placebo (drama)",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-6.55,-3,0,54,0.388888888888889,0.0824074074074074,0.412962962962963,0.0785185185185185,0.267592592592593,0.124814814814815,0.357407407407407,0.128333333333333,1.34172548337105,1.34080572791139,"Liddle, 1990"
"68",NA,57,"Liddle, 1990","1990","cbt","wl",1,"cbt","wlc","cdi","cdi",5,"self-report",21,4.45,11,20.7,3.34,10,14.45,6.74,11,16.9,6.79,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,1,0.181818181818182,0.1,0.181818181818182,0.1,NA,NA,NA,NA,52,32,3,2,NA,"n",NA,"au",NA,NA,NA,NA,NA,9.2,1.15,NA,NA,"cut",NA,NA,NA,-1.17068811438785,-0.750246791707799,"Liddle, 1990_cbt_wlc",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-6.55,-3.8,0,54,0.388888888888889,0.0824074074074074,0.383333333333333,0.0618518518518519,0.267592592592593,0.124814814814815,0.312962962962963,0.125740740740741,1.34172548337105,1.05620073849624,"Liddle, 1990"
"69",NA,59,"Listug-Lunde, 2013","2013","cbt","cau",1,"cwd","cau","cdi","cdi",5,"self-report",21,5.29,8,20.37,4.1,8,14.38,9.93,8,13.25,9.87,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,3,0.375,0.375,0.375,0.375,NA,NA,NA,NA,54,38,3,3,NA,"n",NA,"us",NA,12.38,0.92,12.5,1.07,NA,NA,NA,NA,"cut",NA,NA,NA,-0.869908015768725,-1.01932712956335,"Listug-Lunde, 2013_cwd_cau",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-6.62,-7.12,0,54,0.388888888888889,0.097962962962963,0.377222222222222,0.0759259259259259,0.266296296296296,0.183888888888889,0.24537037037037,0.182777777777778,1.87029743623842,1.44956890143242,"Listug-Lunde, 2013"
"70",NA,60,"Luby, 2012","2012","other psy","other ctr",1,"PCIT-ED intervention (Parent-Child Interaction Therapy Emotion Development)","psychoeducation","PFCâ€“S","pfc",99,"parent_report",42.8,5.8,25,39.8,10.3,18,30.1,11.3,25,33.7,10.6,18,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,2,0.28,0.111111111111111,0.28,0.111111111111111,NA,NA,NA,NA,55,37,NA,NA,NA,"n",NA,"us",NA,4.56,NA,4.06,NA,NA,NA,NA,NA,"mdd",NA,NA,NA,-1.48538011695906,-0.583732057416267,"Luby, 2012_PCIT-ED intervention (Parent-Child Interaction Therapy Emotion Development)_psychoeducation",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-12.7,-6.09999999999999,0,80,0.535,0.0725,0.4975,0.12875,0.37625,0.14125,0.42125,0.1325,1.16,2.42773328207381,"Luby, 2012"
"71",NA,61,"Luby, 2012","2012","other psy","other ctr",1,"PCIT-ED intervention (Parent-Child Interaction Therapy Emotion Development)","psychoeducation","PAPA","papa",99,"parent_report",11.3,4.2,25,9,4.7,18,7.6,4,25,7.5,4.7,18,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,4,0.32,0.222222222222222,0.32,0.222222222222222,NA,NA,NA,NA,56,37,10,5,NA,"n",NA,"us",NA,4.56,NA,4.06,NA,NA,NA,NA,NA,"mdd",NA,NA,NA,-0.902439024390244,-0.319148936170213,"Luby, 2012_PCIT-ED intervention (Parent-Child Interaction Therapy Emotion Development)_psychoeducation",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-3.7,-1.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.84,1.10780062385892,"Luby, 2012"
"72",82,82,"Lundbeck","2020","Fluoxetine","Placebo",0,"Fluoxetine","Placebo","CDRS","cdrs",1,"clinician",61.8,8.9,150,60.6,9.1,153,39.8,8.9,NA,42.4,9.1,NA,-22,14.05,137,-18.2,14.05,137,"CDRS ≥50% improvement",68,137,0.496350364963504,49,137,0.357664233576642,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,"y","ADHD, Insomnia, Anxiety disorder, GAD, Social Anxiety Disorder","International (Bulgaria, Canada, Colombia, Estonia, France, Germany, Hungary, Italy, South Korea, Latvia, Mexico, Poland, Russia, Serbia, South Africa, Spain, Ukraine, UK, USA)","12 to 17",14.8,1.6,14.8,1.6,NA,NA,67.3,68.2,"mdd","124",NA,NA,-2.47191011235955,-2,"Lundbeck_2020_Fluoxetine_Placebo",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,113,0.466666666666667,0.0927083333333333,0.454166666666667,0.0947916666666667,0.2375,0.0927083333333333,0.264583333333333,0.0947916666666667,0.726681957025676,0.735691395943543,"Lundbeck, 2020"
"73",80,80,"Lundbeck","2020","Vortioxetine (10mg)","Placebo",0,"Vortioxetine (10mg)","Placebo","CDRS","cdrs",1,"clinician",61.2,9.4,145,60.6,9.1,153,44.1,9.4,NA,42.4,9.1,NA,-17.1,14.59,126,-18.2,14.05,137,"CDRS ≥50% improvement",53,126,0.420634920634921,49,137,0.357664233576642,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,"y","ADHD, Insomnia, Anxiety disorder, GAD, Social Anxiety Disorder","International (Bulgaria, Canada, Colombia, Estonia, France, Germany, Hungary, Italy, South Korea, Latvia, Mexico, Poland, Russia, Serbia, South Africa, Spain, Ukraine, UK, USA)","12 to 17",14.8,1.66,14.8,1.6,NA,NA,63.3,68.2,"mdd","124",NA,NA,-1.81914893617021,-2,"Lundbeck_2020_Vortioxetine (10mg)_Placebo",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,113,0.460416666666667,0.0979166666666667,0.454166666666667,0.0947916666666667,0.282291666666667,0.0979166666666667,0.264583333333333,0.0947916666666667,0.780627510625156,0.735691395943543,"Lundbeck, 2020"
"74",78,78,"Lundbeck","2020","Vortioxetine (20mg)","Placebo",0,"Vortioxetine (20mg)","Placebo","CDRS","cdrs",1,"clinician",62.5,9.8,159,60.6,9.1,153,43.6,9.8,NA,42.4,9.1,NA,-18.9,14.14,139,-18.2,14.05,137,"CDRS ≥50% improvement",60,139,0.431654676258993,49,137,0.357664233576642,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,"y","ADHD, Insomnia, Anxiety disorder, GAD, Social Anxiety Disorder","International (Bulgaria, Canada, Colombia, Estonia, France, Germany, Hungary, Italy, South Korea, Latvia, Mexico, Poland, Russia, Serbia, South Africa, Spain, Ukraine, UK, USA)","12 to 17",14.5,1.63,14.8,1.6,NA,NA,59.9,68.2,"mdd","124",NA,NA,-1.92857142857143,-2,"Lundbeck_2020_Vortioxetine (20mg)_Placebo",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,113,0.473958333333333,0.102083333333333,0.454166666666667,0.0947916666666667,0.277083333333333,0.102083333333333,0.264583333333333,0.0947916666666667,0.777190554003781,0.735691395943543,"Lundbeck, 2020"
"75",NA,62,"Makover, 2019","2019","other psy","cau",1,"The High School Transition Program (HSTP)","cau","smfq","smfq",7,"self-report",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,57,61,NA,NA,NA,"n",NA,"us",NA,NA,NA,NA,NA,13.5,NA,NA,NA,"cut",NA,NA,NA,NA,NA,"Makover, 2019_The High School Transition Program (HSTP)_cau",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,26,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Makover, 2019"
"76",NA,63,"March, 2004","2004","cbt",NA,1,"cbt",NA,"cdrs-r","cdrs",1,"clinician",59.64,4.52,111,NA,NA,NA,42.06,9.18,111,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,NA,0.108108108108108,NA,0.108108108108108,NA,NA,NA,NA,NA,58,54,10,NA,NA,"n",NA,"us",NA,NA,NA,NA,NA,14.6,1.5,NA,NA,"mdd",NA,NA,NA,-2.56642335766423,NA,"March, 2004_cbt_NA",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-17.58,NA,17,113,0.444166666666667,0.0470833333333333,NA,NA,0.261041666666667,0.095625,NA,NA,0.42901941408013,NA,"March, 2004"
"77",56,56,"March","2004","Fluoxetine","Placebo",0,"Fluoxetine","Placebo","CDRS","cdrs",1,"clinician",58.94,4,109,61.18,4.27,112,36.3,8.18,109,41.77,7.99,112,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,12,0.155963302752294,0.107142857142857,0.155963302752294,0.107142857142857,73,53,71,50,NA,NA,NA,NA,12,"y","Anxiety, disruptive behaviour, obsessive-compulsice/tic, substance use, attention-deficit/hyperactivity","USA","12 to 17",NA,NA,NA,NA,14.6,1.5,54.4,54.4,"mdd","13",NA,NA,-3.7175697865353,-3.16639477977161,"March_2004_Fluoxetine_Placebo",-22.64,7.08,109,NA,NA,66,109,0,18,109,10,109,-19.41,6.93,112,NA,NA,39,112,0,23,112,3,112,NA,NA,17,113,0.436875,0.0416666666666667,0.460208333333333,0.0444791666666667,0.201041666666667,0.0852083333333333,0.258020833333333,0.0832291666666667,0.383130514088461,0.40347707493735,"March, 2004"
"78",NA,65,"Martinovic, 2006","2006","cbt","cau",1,"cbt","cau","ham-d","hamd",2,"clinician",5.9,0.8,16,5.7,0.7,16,3.3,1.29,15,5.8,1.98,15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,1,0.3125,0.0625,0.333333333333333,0.0666666666666667,NA,NA,NA,NA,60,68,6,1,NA,"n",NA,"eu",NA,NA,NA,NA,NA,17.4,1.6,NA,NA,"sub",NA,NA,NA,-2.48803827751196,0.0746268656716415,"Martinovic, 2006_cbt_cau",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-2.6,0.0999999999999996,0,52,0.113461538461538,0.0153846153846154,0.109615384615385,0.0134615384615385,0.0634615384615385,0.0248076923076923,0.111538461538462,0.0380769230769231,0.2,0.175,"Martinovic, 2006"
"79",NA,68,"Moeini, 2019","2019","cbt","cau",1,"DAD (Dorehye Amozeshie Dokhtaran)","cau","ces-d","ces_d",11,"self-report",24.6,11.7,64,22.3,11.8,64,18.5,14,64,21.4,15.6,64,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,22,21,0.34375,0.328125,0.34375,0.328125,NA,NA,NA,NA,63,100,21,16,NA,"n",NA,"other",NA,16.2,0.68,16.5,0.6,NA,NA,NA,NA,"cut",NA,NA,NA,-0.474708171206226,-0.0656934306569345,"Moeini, 2019_DAD (Dorehye Amozeshie Dokhtaran)_NA",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-6.1,-0.900000000000002,0,60,0.41,0.195,0.371666666666667,0.196666666666667,0.308333333333333,0.233333333333333,0.356666666666667,0.26,1.4625,1.475,"Moeini, 2019"
"80",NA,69,"Mufson, 1999","1999","ipt","other ctr",1,"ipt","clinical monitoring","ham-d","hamd",2,"clinician",19.2,7.5,24,18.7,8.6,24,6.3,7.7,24,11.8,8.9,24,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,10,0.708333333333333,0.416666666666667,0.708333333333333,0.416666666666667,NA,NA,NA,NA,64,73,16,9,NA,"n",NA,"us",NA,15.7,1.4,15.9,1.7,NA,NA,NA,NA,"mdd",NA,NA,NA,-1.69736842105263,-0.788571428571428,"Mufson, 1999_ipt_clinical monitoring",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-12.9,-6.9,0,52,0.369230769230769,0.144230769230769,0.359615384615385,0.165384615384615,0.121153846153846,0.148076923076923,0.226923076923077,0.171153846153846,1.53093108923949,1.75546764899461,"Mufson, 1999"
"81",NA,71,"Mufson, 2004","2004","ipt","cau",1,"ipt","cau","ham-d","hamd",2,"clinician",18.9,5.9,34,18.3,5,29,8.7,8,34,12.8,8.4,29,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,19,7,0.558823529411765,0.241379310344828,0.558823529411765,0.241379310344828,NA,NA,NA,NA,66,84,18,10,NA,"n",NA,"us",NA,15.3,2.1,14.9,1.7,NA,NA,NA,NA,"mood",NA,NA,NA,-1.46762589928058,-0.82089552238806,"Mufson, 2004_ipt_cau",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-10.2,-5.5,0,52,0.363461538461538,0.113461538461538,0.351923076923077,0.0961538461538462,0.167307692307692,0.153846153846154,0.246153846153846,0.161538461538462,1.0118416523408,0.928476690885259,"Mufson, 2004"
"82",1,1,"Organon","2002a","Mirtazapine","Placebo",0,"Mirtazapine","Placebo","CDRS","cdrs",1,"clinician",50.93,9.32875,82,51.93,9.29964285714286,44,35.08,10.8323214285714,82,37.24,10.8732142857143,44,NA,NA,NA,NA,NA,NA,"missing",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,"n",NA,NA,"7 to 17",12.3,NA,12.4,NA,NA,NA,47.6,56.8,"mdd","17",NA,NA,-1.5723370710882,-1.45641243537993,"Organon_2002a_Mirtazapine_Placebo",-15.85,12.54,82,5,82,NA,NA,NA,13,82,NA,82,-14.69,12.56,44,1,44,NA,NA,NA,9,44,NA,44,NA,NA,17,113,0.3534375,0.0971744791666667,0.363854166666667,0.0968712797619048,0.188333333333333,0.112836681547619,0.210833333333333,0.113262648809524,1.03018809887072,1.40197391097507,"Organon, 2002a"
"83",2,2,"Organon","2002b","Mirtazapine","Placebo",0,"Mirtazapine","Placebo","CDRS","cdrs",1,"clinician",48.87,9.32875,88,47.57,9.29964285714286,45,35.39,10.8323214285714,82,38.76,10.8732142857143,41,NA,NA,NA,NA,NA,NA,"missing",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,"n",NA,NA,"7 to 17",11.9,NA,12.3,NA,NA,NA,50,50.5,"mdd","15",NA,NA,-1.33723051850277,-0.873450888747256,"Organon_2002b_Mirtazapine_Placebo",-13.48,12.24,83,4,88,NA,NA,NA,19,88,NA,88,-8.81,12.22,41,2,45,NA,NA,NA,9,45,NA,45,NA,NA,17,113,0.331979166666667,0.0971744791666667,0.3184375,0.0968712797619048,0.1915625,0.112836681547619,0.226666666666667,0.113262648809524,0.9944480913512,1.38630890633612,"Organon, 2002b"
"84",59,59,"Paxil (GlaxoSmithKline)","2009","Paroxetine","Placebo",0,"Paroxetine","Placebo","CDRS","cdrs",1,"clinician",NA,9.32875,29,NA,9.29964285714286,27,NA,10.8323214285714,29,NA,10.8732142857143,27,-16.5,13.19,29,-11.9,13.2,27,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,"n",NA,"Japan","7 to 17",14.4,1.99,14.8,2.62,NA,NA,55.2,66.7,"mdd","33",NA,NA,NA,NA,"Paxil (GlaxoSmithKline)_2009_Paroxetine_Placebo",-16.5,13.19,29,1,29,15,29,0,4,29,0,29,-11.9,13.2,27,2,27,11,27,0,3,27,3,27,NA,NA,17,113,NA,0.0971744791666667,NA,0.0968712797619048,NA,0.112836681547619,NA,0.113262648809524,1.73230538601917,1.78971710231294,"Paxil (GlaxoSmithKline), 2009"
"85",NA,73,"Poole, 2017","2017","other psy","cau",1,"Behaviour Exchange Systems Therapy for adolescent depression (BEST MOOD)","supportive parenting program","smfq","smfq",7,"self-report",18.8,1.38,27,17.5,1.35,26,13.23,1.47,25,13.33,1.44,26,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA,NA,68,73.4,NA,NA,NA,"n",NA,"au",NA,15,1.3,15.3,1.4,15.2,1.4,NA,NA,"mood",NA,NA,NA,-3.90877192982456,-2.98924731182796,"Poole, 2017_Behaviour Exchange Systems Therapy for adolescent depression (BEST MOOD)_supportive parenting program",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-5.57,-4.17,0,26,0.723076923076923,0.0530769230769231,0.673076923076923,0.0519230769230769,0.508846153846154,0.0565384615384615,0.512692307692308,0.0553846153846154,0.265581123827228,0.264756782436548,"Poole, 2017"
"86",61,61,"Puig-Antich","1987","Imipramine","Placebo",0,"Imipramine","Placebo","K-SADS-L","ksads",6,"clinician",3.1,0.43,20,3,0.66,22,1.9,0.68,16,1.9,0.86,22,NA,NA,NA,NA,NA,NA,"Responder: if K-SADS scores in both depressed mood and anhedonia were ≤2. Non-responder: if K-SADS score for at least one of these two key items were ≥3.",9,16,0.5625,15,22,0.681818181818182,6,7,0.3,0.318181818181818,0.375,0.318181818181818,11,13,8,11,NA,NA,NA,NA,5,"n",NA,"USA","missing",9.03,1.58,9.18,1.28,NA,NA,62.5,59,"mdd","33",NA,NA,-2.16216216216216,-1.44736842105263,"Puig-Antich_1987_Imipramine_Placebo",-1.2,0.6,16,0,20,9,16,4,4,20,NA,NA,-1.1,0.78,22,0,22,15,22,0,0,22,NA,NA,NA,NA,1,4,0.7,0.143333333333333,0.666666666666667,0.22,0.3,0.226666666666667,0.3,0.286666666666667,0.096150923032491,0.140712472794703,"Puig-Antich, 1987"
"87",NA,74,"Reed, 1994","1994","other psy","other ctr",1,"Structured Learning Therapy (SLT)","art and imagery exercises","bdi","bdi",4,"self-report",NA,NA,12,NA,NA,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,69,50,NA,NA,NA,"n",NA,"us",NA,NA,NA,NA,NA,NA,NA,NA,NA,"mood",NA,NA,NA,NA,NA,"Reed, 1994_Structured Learning Therapy (SLT)_art and imagery exercises",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,63,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Reed, 1994"
"88",NA,79,"Reynolds, 1986","1986","cbt","other ctr",1,"cbt","Relaxation training","bdi","bdi",4,"self-report",21.11,7.75,9,17.09,6.36,11,6.36,3.15,6,5.77,4,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,6,0.666666666666667,0.545454545454545,1,0.75,NA,NA,NA,NA,74,63,NA,NA,NA,"n",NA,"us",NA,NA,NA,NA,NA,15.65,NA,NA,NA,"cut",NA,NA,NA,-2.70642201834862,-2.18532818532819,"Reynolds, 1986_cbt_Relaxation training",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-14.75,-11.32,0,63,0.335079365079365,0.123015873015873,0.271269841269841,0.100952380952381,0.100952380952381,0.05,0.0915873015873016,0.0634920634920635,2.58333333333333,1.91761215151458,"Reynolds, 1986"
"89",NA,76,"Reynolds, 1986","1986","cbt","wl",1,"cbt","wlc","bdi","bdi",4,"self-report",21.11,7.75,9,16.9,5.48,10,6.36,3.15,6,18.31,9.82,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,3,0.555555555555556,0.3,0.833333333333333,0.3,NA,NA,NA,NA,71,63,5,2,NA,"n",NA,"us",NA,NA,NA,NA,NA,15.65,NA,NA,NA,"cut",NA,NA,NA,-2.70642201834862,0.184313725490196,"Reynolds, 1986_cbt_wlc",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-14.75,1.41,0,63,0.335079365079365,0.123015873015873,0.268253968253968,0.086984126984127,0.100952380952381,0.05,0.290634920634921,0.155873015873016,2.58333333333333,1.73292815777227,"Reynolds, 1986"
"90",NA,83,"Rohde, 2004","2004","cbt","other ctr",1,"cbt","life skills/tutoring","ham-d","hamd",2,"clinician",14.2,5.2,45,6,6.3,48,6,6.3,44,8.3,5.4,47,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,24,4,0.533333333333333,0.0833333333333333,0.545454545454545,0.0851063829787234,NA,NA,NA,NA,78,48,25,8,NA,"y",NA,"us",NA,15.1,1.5,15.1,1.3,15.1,1.4,NA,NA,"mdd",NA,NA,"conduct disorder",-1.42608695652174,0.393162393162393,"Rohde, 2004_cbt_life skills/tutoring",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-8.2,2.3,0,52,0.273076923076923,0.1,0.115384615384615,0.121153846153846,0.115384615384615,0.121153846153846,0.159615384615385,0.103846153846154,0.775170232199927,0.909326673973661,"Rohde, 2004"
"91",NA,84,"Rohde, 2014a","2014","cbt","other ctr",1,"cognitive behavioral intervention (CB)","educational brochure control","K-SADS (adapted)","ksads",6,"clinician",1.37,0.35,126,1.38,0.36,124,1.4,0.32,126,1.5,0.41,124,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,1,0,0.00806451612903226,0,0.00806451612903226,NA,NA,NA,NA,79,68,NA,NA,NA,"n",NA,"us",NA,NA,NA,NA,NA,15.5,1.2,NA,NA,"cut",NA,NA,NA,0.0895522388059696,0.311688311688312,"Rohde, 2014a_cognitive behavioral intervention (CB)_educational brochure control",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.0299999999999998,0.12,1,4,0.123333333333333,0.116666666666667,0.126666666666667,0.12,0.133333333333333,0.106666666666667,0.166666666666667,0.136666666666667,0.0311804782231162,0.0323289543648195,"Rohde, 2014a"
"92",NA,85,"Rossello, 1999","1999","cbt","wl",1,"cbt","wlc","cdi","cdi",5,"self-report",20.12,6.95,25,20.13,5.99,23,13.28,7.61,21,15.83,6.83,18,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,4,0.28,0.173913043478261,0.333333333333333,0.222222222222222,NA,NA,NA,NA,80,54,7,4,NA,"n",NA,"us",NA,NA,NA,NA,NA,14.7,1.4,NA,NA,"mood",NA,NA,NA,-0.93956043956044,-0.670826833073323,"Rossello, 1999_cbt_wlc",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-6.84,-4.3,0,54,0.372592592592593,0.128703703703704,0.372777777777778,0.110925925925926,0.245925925925926,0.140925925925926,0.293148148148148,0.126481481481481,1.39,1.24900134020188,"Rossello, 1999"
"93",NA,86,"Rossello, 1999","1999","ipt","wl",1,"ipt","wlc","cdi","cdi",5,"self-report",21.21,7.53,23,20.13,5.99,23,10.79,6.51,19,15.83,6.83,18,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,3,0.347826086956522,0.130434782608696,0.421052631578947,0.166666666666667,NA,NA,NA,NA,81,54,9,4,NA,"n",NA,"us",NA,NA,NA,NA,NA,14.7,1.4,NA,NA,"mood",NA,NA,NA,-1.48433048433048,-0.670826833073323,"Rossello, 1999_ipt_wlc",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-10.42,-4.3,0,54,0.392777777777778,0.139444444444444,0.372777777777778,0.110925925925926,0.199814814814815,0.120555555555556,0.293148148148148,0.126481481481481,1.57011353784977,1.24900134020188,"Rossello, 1999"
"94",NA,87,"Sanford, 2006","2006","other psy","cau",1,"Family Psychoeducation (FPE) + cau","cau","rads","rads",8,"self-report",NA,NA,16,NA,NA,15,NA,NA,16,NA,NA,15,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,82,65,NA,NA,NA,"n",NA,"can",NA,15.6,1.1,16.1,1.6,NA,NA,NA,NA,"MDD",NA,NA,NA,NA,NA,"Sanford, 2006_Family Psychoeducation (FPE) + cau_cau",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,30,120,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Sanford, 2006"
"95",NA,88,"Santomauro, 2016","2016","cbt","wl",1,"cbt","wlc","dass","dass",99,"self-report",24.2,8.97,11,21.6,11.03,12,17.2,8.95,10,23.93,11.58,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2,0.181818181818182,0.166666666666667,0.2,0.2,NA,NA,NA,NA,83,40,3,1,NA,"y",NA,"au",NA,16,1.33,15.5,1.43,NA,NA,NA,NA,"cut",NA,NA,"ASD",-0.78125,0.20610349402919,"Santomauro, 2016_cbt_wlc",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-7,2.33,0,42,0.576190476190476,0.213571428571429,0.514285714285714,0.262619047619048,0.40952380952381,0.213095238095238,0.569761904761905,0.275714285714286,2.70455676086254,3.18408673458079,"Santomauro, 2016"
"96",NA,91,"Shirk, 2014","2014","cbt","cau",1,"m-cbt (modified for interpersonal trauma)","cau","bdi-ii","bdi",4,"self-report",29.85,10.56,20,32.21,12.99,23,21.35,11.62,15,19.38,13.47,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,12,0.1,0.521739130434783,0.133333333333333,0.6,NA,NA,NA,NA,84,83.7,NA,NA,NA,"y",NA,"us",NA,15.25,1.52,15.69,1.55,15.48,1.53,NA,NA,"mood",NA,NA,"at least one incident of interpersonal trauma (physical, sexual or verbal/emotional abuse)",-0.766456266907124,-0.969765684051398,"Shirk, 2014_m-cbt (modified for interpersonal trauma)_cau",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-8.5,-12.83,0,63,0.473809523809524,0.167619047619048,0.511269841269841,0.206190476190476,0.338888888888889,0.184444444444444,0.307619047619048,0.213809523809524,2.36128778423978,2.7086022386014,"Shirk, 2014"
"97",NA,92,"Shomaker, 2016","2016","cbt","other ctr",1,"cbt","psychoeducation","ces-d","ces_d",11,"self-report",25.3,7.3,61,24.5,7.5,58,13.4,7.3,61,13.8,7.5,58,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,85,100,NA,NA,NA,"n",NA,"us",NA,15,1.6,15.1,1.6,NA,NA,NA,NA,"sub",NA,NA,NA,-1.63013698630137,-1.42666666666667,"Shomaker, 2016_cbt_psychoeducation",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-11.9,-10.7,0,60,0.421666666666667,0.121666666666667,0.408333333333333,0.125,0.223333333333333,0.121666666666667,0.23,0.125,0.934669223510141,0.984798246447919,"Shomaker, 2016"
"98",NA,94,"Srivastava, 2020","2020","cbt","cau",1,"cCBT","cau","cdrs-r","cdrs",1,"self-report",67.8,3.1,11,66.9,3.4,10,33.7,11.2,10,45.3,9.7,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,0,0.272727272727273,0,0.3,0,NA,NA,NA,NA,87,24,NA,NA,NA,"n",NA,"oth",NA,16,1.5,16.1,1.3,16.05,1.5,NA,NA,"mdd",NA,NA,NA,-4.76923076923077,-3.29770992366412,"Srivastava, 2020_cCBT_cau",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-34.1,-21.6,17,113,0.529166666666667,0.0322916666666667,0.519791666666667,0.0354166666666667,0.173958333333333,0.116666666666667,0.294791666666667,0.101041666666667,0.934685168191067,1.07517440445725,"Srivastava, 2020"
"99",NA,95,"Stallard, 2012","2012","cbt","other ctr",1,"cbt","attention control","smfq","smfq",7,"self-report",10.64,4.91,392,10.6,4.67,374,8.22,6.45,296,8.5,5.88,308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,89,82,0.227040816326531,0.219251336898396,0.300675675675676,0.266233766233766,NA,NA,NA,NA,88,65,NA,NA,NA,"n",NA,"uk",NA,14.3,NA,NA,NA,NA,NA,NA,NA,"cut",NA,NA,NA,-0.426056338028169,-0.398104265402843,"Stallard, 2012_cbt_attention control",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-2.42,-2.1,0,26,0.409230769230769,0.188846153846154,0.407692307692308,0.179615384615385,0.316153846153846,0.248076923076923,0.326923076923077,0.226153846153846,0.247992449687568,0.241479951227674,"Stallard, 2012"
"100",NA,96,"Stallard, 2012","2012","cbt","cau",1,"cbt","cau","smfq","smfq",7,"self-report",10.64,4.91,392,10.56,4.93,298,8.22,6.45,296,6.81,5.7,242,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,102,95,0.260204081632653,0.318791946308725,0.344594594594595,0.392561983471074,NA,NA,NA,NA,89,65,97,90,NA,"n",NA,"uk",NA,14.3,NA,NA,NA,NA,NA,NA,NA,"cut",NA,NA,NA,-0.426056338028169,-0.705550329256821,"Stallard, 2012_cbt_cau",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-2.42,-3.75,0,26,0.409230769230769,0.188846153846154,0.406153846153846,0.189615384615385,0.316153846153846,0.248076923076923,0.261923076923077,0.219230769230769,0.247992449687568,0.285587232057202,"Stallard, 2012"
"101",NA,99,"Stark, 1987","1987","pst","wl",1,"pst","wlc","cdrs-r","cdrs",1,"clinician",33.5,10.27,10,30.33,6.28,9,24.16,6.01,10,28.15,6.21,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA,NA,92,43,1,0.2,NA,"n",NA,"us",NA,11.1,NA,11.32,NA,11.17,NA,NA,NA,"cut",NA,NA,NA,-1.14742014742015,-0.349079263410729,"Stark, 1987_pst_wlc",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-9.34,-2.18,17,113,0.171875,0.106979166666667,0.138854166666667,0.0654166666666667,0.0745833333333333,0.0626041666666667,0.116145833333333,0.0646875,3.24765915699293,2.09333333333333,"Stark, 1987"
"102",NA,103,"Stark, 1987","1987","other psy","wl",1,"self control","wlc","cdrs-r","cdrs",1,"clinician",37.22,8.36,9,30.33,6.28,9,22.91,4.36,9,28.15,6.21,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,NA,NA,NA,NA,96,43,1,0.2,NA,"n",NA,"us",NA,11.2,NA,11.32,NA,11.17,NA,NA,NA,"cut",NA,NA,NA,-2.25,-0.349079263410729,"Stark, 1987_self control_wlc",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-14.31,-2.18,17,113,0.210625,0.0870833333333333,0.138854166666667,0.0654166666666667,0.0615625,0.0454166666666667,0.116145833333333,0.0646875,2.78666666666667,2.09333333333333,"Stark, 1987"
"103",NA,107,"Stice, 2008","2008","cbt","cau",1,"cbt based bibliotherapy","assessment only","bdi","bdi",4,"self-report",18.2,7.53,80,19.6,9.23,84,14.25,8.98,80,16.71,9.74,84,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,19,21,0.2375,0.25,0.2375,0.25,NA,NA,NA,NA,100,56,NA,NA,NA,"n",NA,"us",NA,NA,NA,NA,NA,15.6,1.2,NA,NA,"sub",NA,NA,NA,-0.478497880072683,-0.304691618344755,"Stice, 2008_cbt based bibliotherapy_assessment only",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-3.95,-2.89,0,63,0.288888888888889,0.11952380952381,0.311111111111111,0.146507936507937,0.226190476190476,0.142539682539683,0.265238095238095,0.154603174603175,0.841879593528671,1.0070755634391,"Stice, 2008"
"104",NA,105,"Stice, 2008","2008","cbt","cau",1,"cbt","assessment only","bdi","bdi",4,"self-report",20.03,10.35,89,19.6,9.23,84,10.77,9.04,89,16.71,9.74,84,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,41,22,0.460674157303371,0.261904761904762,0.460674157303371,0.261904761904762,NA,NA,NA,NA,98,56,42,20,NA,"n",NA,"us",NA,NA,NA,NA,NA,15.6,1.2,NA,NA,"sub",NA,NA,NA,-0.95513151108819,-0.304691618344755,"Stice, 2008_cbt_assessment only",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-9.26,-2.89,0,63,0.317936507936508,0.164285714285714,0.311111111111111,0.146507936507937,0.170952380952381,0.143492063492063,0.265238095238095,0.154603174603175,1.09709780580658,1.0070755634391,"Stice, 2008"
"105",NA,109,"Stice, 2008","2008","sup","cau",1,"sup","assessment only","bdi","bdi",4,"self-report",20.27,9.83,88,19.6,9.23,84,14.67,10.62,88,16.71,9.74,84,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,27,27,0.306818181818182,0.321428571428571,0.306818181818182,0.321428571428571,NA,NA,NA,NA,102,56,30,20,NA,"n",NA,"us",NA,NA,NA,NA,NA,15.6,1.2,NA,NA,"sub",NA,NA,NA,-0.547677261613692,-0.304691618344755,"Stice, 2008_sup_assessment only",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-5.6,-2.89,0,63,0.321746031746032,0.156031746031746,0.311111111111111,0.146507936507937,0.232857142857143,0.168571428571429,0.265238095238095,0.154603174603175,1.04788152088783,1.0070755634391,"Stice, 2008"
"106",NA,111,"Stikkelbroek, 2020","2020","cbt","cau",1,"cbt","cau","K-SADS","ksads",6,"clinician",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,104,82,NA,NA,NA,"n",NA,"eu",NA,16.9,2.2,16.3,2,16.6,2.1,NA,NA,"mdd",NA,NA,NA,NA,NA,"Stikkelbroek, 2020_cbt_cau",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Stikkelbroek, 2020"
"107",NA,112,"Szigethy, 2007","2007","cbt","cau",1,"cbt","cau","cdi","cdi",5,"self-report",25.7,10.8,22,21.8,8.1,19,10.7,8,21,16.7,11.1,19,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11,6,0.5,0.315789473684211,0.523809523809524,0.315789473684211,NA,NA,NA,NA,105,51,13,6,NA,"n",NA,"us",NA,14.95,2.33,15.02,1.83,NA,NA,NA,NA,"sub",NA,NA,NA,-1.59574468085106,-0.53125,"Szigethy, 2007_cbt_cau",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-15,-5.1,0,54,0.475925925925926,0.2,0.403703703703704,0.15,0.198148148148148,0.148148148148148,0.309259259259259,0.205555555555556,2.30256773664059,1.85826744435155,"Szigethy, 2007"
"108",NA,114,"Tang, 2009","2009","ipt","cau",1,"Intensive Interpersonal Psychotherapy for depressed adolescents with suicidal risk (IPT-A-IN)","school-based supportive intervention and psychoeducation","bdi-ii","bdi",4,"self-report",32.66,10.06,35,32.32,8.7,38,19.97,14.68,35,31.58,12.01,38,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,3,0.485714285714286,0.0789473684210526,0.485714285714286,0.0789473684210526,NA,NA,NA,NA,107,66,NA,NA,NA,"y",NA,"eas",NA,15.26,1.7,15.24,1.65,NA,NA,NA,NA,"cut",NA,NA,"suicidality",-1.02586903799515,-0.0714630613230325,"Tang, 2009_Intensive Interpersonal Psychotherapy for depressed adolescents with suicidal risk (IPT-A-IN)_school-based supportive intervention and psychoeducation",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-12.69,-0.740000000000002,0,63,0.518412698412698,0.15968253968254,0.513015873015873,0.138095238095238,0.316984126984127,0.233015873015873,0.501269841269841,0.190634920634921,1.70045036051378,1.41132636383763,"Tang, 2009"
"109",NA,115,"Topooco, 2018","2018","cbt","other ctr",1,"cbt","attention control","bdi-ii","bdi",4,"self-report",33.1,9.4,33,32.3,10.2,37,19.9,7.2,33,25.2,7.8,37,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11,2,0.333333333333333,0.0540540540540541,0.333333333333333,0.0540540540540541,NA,NA,NA,NA,108,94,17,6,NA,"n",NA,"eu",NA,17.2,1,16.9,1.1,NA,NA,NA,NA,"cut",NA,NA,NA,-1.59036144578313,-0.788888888888889,"Topooco, 2018_cbt_attention control",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-13.2,-7.1,0,63,0.525396825396825,0.149206349206349,0.512698412698413,0.161904761904762,0.315873015873016,0.114285714285714,0.4,0.123809523809524,1.63632996598356,1.67686967051464,"Topooco, 2018"
"110",NA,117,"Topooco, 2019","2019","cbt","other ctr",1,"icbt","minimal attention controlÂ ","bdi","bdi",4,"self-report",31.6,10,35,28.8,7.9,35,16,11.3,31,24.8,10.4,35,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,4,0.342857142857143,0.114285714285714,0.387096774193548,0.114285714285714,NA,NA,NA,NA,110,96,NA,NA,NA,"n",NA,"eu",NA,17.5,1.1,17.5,1.2,NA,NA,NA,NA,"cut",NA,NA,NA,-1.46478873239437,-0.437158469945355,"Topooco, 2019_icbt_minimal attention controlÂ ",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-15.6,-4,0,63,0.501587301587302,0.158730158730159,0.457142857142857,0.125396825396825,0.253968253968254,0.179365079365079,0.393650793650794,0.165079365079365,1.69030850945703,1.33534372247106,"Topooco, 2019"
"111",63,63,"Von Knorring","2006","Citalopram","Placebo",0,"Citalopram","Placebo","MADRS","madrs",3,"clinician",30,5.5,124,30,5.5,120,17.91,5.5,79,18.09,5.5,74,NA,NA,NA,NA,NA,NA,"50% improvement from baseline",NA,NA,0.61,NA,NA,0.59,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,"n",NA,"European, multi-centered (31 recruitment sites)","13 to 18",16,1,16,1,16,1,NA,NA,"mdd","31",NA,NA,-2.19818181818182,-2.16545454545455,"Von Knorring_2006_Citalopram_Placebo",-12.09,16.36,96,14,124,48,121,3,45,124,9,124,-11.91,15.93,91,9,120,44,112,8,46,120,5,120,NA,NA,0,60,0.5,0.0916666666666667,0.5,0.0916666666666667,0.2985,0.0916666666666667,0.3015,0.0916666666666667,0.493914580573631,0.502079011046402,"Von Knorring, 2006"
"112",NA,118,"Vostanis, 1996","1996","cbt","other ctr",1,"cbt","non-focused intervention","mfq","mfq",7,"self-report",33.4,12.2,29,28.6,14.4,28,17.6,5.2,29,18.4,15.8,28,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,15,12,0.517241379310345,0.428571428571429,0.517241379310345,0.428571428571429,NA,NA,NA,NA,111,56,NA,NA,NA,"n",NA,"uk",NA,NA,NA,NA,NA,12.7,NA,NA,NA,"mdd",NA,NA,NA,-1.81609195402299,-0.675496688741722,"Vostanis, 1996_cbt_non-focused intervention",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-15.8,-10.2,0,66,0.506060606060606,0.184848484848485,0.433333333333333,0.218181818181818,0.266666666666667,0.0787878787878788,0.278787878787879,0.239393939393939,2.26548312576003,2.72134420566644,"Vostanis, 1996"
"113",NA,119,"Vostanis, 1996","1996","cbt","other ctr",1,"cbt","non-focused intervention","mfq","mfq",7,"parent_report",30,12,29,32.5,15.1,28,13.4,9.2,29,19.4,13.7,28,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,15,11,0.517241379310345,0.392857142857143,0.517241379310345,0.392857142857143,NA,NA,NA,NA,112,56,13,11,NA,"n",NA,"uk",NA,NA,NA,NA,NA,12.7,NA,NA,NA,"mdd",NA,NA,NA,-1.56603773584906,-0.909722222222222,"Vostanis, 1996_cbt_non-focused intervention",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-16.6,-13.1,0,66,0.454545454545455,0.181818181818182,0.492424242424242,0.228787878787879,0.203030303030303,0.139393939393939,0.293939393939394,0.207575757575758,2.22834405812462,2.85363177121967,"Vostanis, 1996"
"114",64,64,"Wagner","2003","Sertraline","Placebo",0,"Sertraline","Placebo","CDRS","cdrs",1,"clinician",64.3,11,189,64.6,11,187,41.46,11,185,44.41,11,179,-22.84,NA,NA,-20.19,NA,NA,"40% improvement",128,185,0.691891891891892,106,179,0.592178770949721,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,"y","Most common were oppositional defiant disorder, anxiety, adjustment reaction and phobic disorders.","International (USA, India, Canada, Costa Rica, Mexico)","6 to 17",NA,NA,NA,NA,NA,NA,57.1,44.9,"mdd","53",NA,NA,-2.07636363636364,-1.83545454545455,"Wagner_2003_Sertraline_Placebo",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,113,0.492708333333333,0.114583333333333,0.495833333333333,0.114583333333333,0.254791666666667,0.114583333333333,0.285520833333333,0.114583333333333,0.800132264198639,0.804399666539844,"Wagner, 2003"
"115",66,66,"Wagner","2004","Citalopram","Placebo",0,"Citalopram","Placebo","CDRS","cdrs",1,"clinician",58.8,10.9,89,57.8,11.1,85,37.1,10.9,89,41.3,11.1,85,NA,NA,NA,NA,NA,NA,"CDRS score ≤28",32,89,0.359550561797753,20,85,0.235294117647059,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,"y","Dysthmia, enuresis","USA","7 to 17",12.1,3.1,12.1,2.8,12.1,NA,52.8,54.1,"mdd","21",NA,NA,-1.99082568807339,-1.48648648648649,"Wagner_2004_Citalopram_Placebo",-21.7,15.09,89,5,93,42,89,NA,22,93,1,93,-16.5,14.75,85,5,85,38,85,NA,18,85,2,85,NA,NA,17,113,0.435416666666667,0.113541666666667,0.425,0.115625,0.209375,0.113541666666667,0.253125,0.115625,1.15539768920693,1.20396404089354,"Wagner, 2004"
"116",68,68,"Wagner","2006","Escitalopram","Placebo",0,"Escitalopram","Placebo","CDRS","cdrs",1,"clinician",54.5,9.32875,131,56.6,9.29964285714286,133,32.6,10.8323214285714,NA,36.4,10.8732142857143,NA,-21.9,NA,129,-20.2,NA,132,"CDRS score ≤28",59,129,0.457364341085271,50,132,0.378787878787879,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,"y","Anxiety disorders (e.g. GAD, panic disorder, social phobia, specific phobia)","USA","6 to 17",12.2,2.9,12.4,3,12.3,3,51.9,51.9,"mdd","25",NA,NA,-2.1725035871818,-2.00269102754762,"Wagner_2006_Escitalopram_Placebo",-21.9,13.5,129,2,132,81,129,NA,30,132,1,132,-20.2,13.5,132,2,136,69,132,NA,21,136,0,136,NA,NA,17,113,0.390625,0.0971744791666667,0.4125,0.0968712797619048,0.1625,0.112836681547619,0.202083333333333,0.113262648809524,0.815056671857666,0.806381303444235,"Wagner, 2006"
"117",92,92,"Weihs","2018","Desvenlafaxine","Placebo",0,"Desvenlafaxine","Placebo","CDRS","cdrs",1,"clinician",56.337,9.585,115,57.06,8.91,112,33.737,9.585,NA,33.96,8.91,NA,-22.6,12.547,115,-23.1,12.488,112,"missing",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,"y","ADHD, non-suicidal inurious behaviour, insomnia, generalised anxiety disorder, oppositional defiant disorder","USA, Mexico","7 to 17",12.869,1.46,12.65,1.425,NA,NA,55.139,57.5,"mdd","43",NA,NA,-2.35785080855503,-2.59259259259259,"Weihs_2018_Desvenlafaxine_Placebo",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,113,0.409760416666667,0.09984375,0.417291666666667,0.0928125,0.17434375,0.09984375,0.176666666666667,0.0928125,0.893805858698341,0.841915863628054,"Weihs, 2018"
"118",94,94,"Weihs","2018","Fluoxetine","Placebo",0,"Fluoxetine","Placebo","CDRS","cdrs",1,"clinician",56.256,8.34,112,57.06,8.91,112,31.456,8.34,NA,33.96,8.91,NA,-24.8,12.382,112,-23.1,12.488,112,"missing",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,"y","ADHD, non-suicidal inurious behaviour, insomnia, generalised anxiety disorder, oppositional defiant disorder","USA, Mexico","7 to 17",12.65,1.479,12.65,1.425,NA,NA,50.74,57.5,"mdd","43",NA,NA,-2.97362110311751,-2.59259259259259,"Weihs_2018_Fluoxetine_Placebo",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,113,0.408916666666667,0.086875,0.417291666666667,0.0928125,0.150583333333333,0.086875,0.176666666666667,0.0928125,0.788055926224239,0.841915863628054,"Weihs, 2018"
"119",NA,120,"Weisz, 1997","1997","cbt","cau",1,"cbt","nt","cdrs-r","cdrs",1,"clinician",45.25,16.01,16,38.38,11.15,32,33.19,10.86,16,34.94,10.93,32,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,3,0.0625,0.09375,0.0625,0.09375,NA,NA,NA,NA,113,46,3,2,NA,"n",NA,"us",NA,9.4,NA,9.7,NA,9.6,NA,NA,NA,"cut",NA,NA,NA,-0.897655377744697,-0.311594202898551,"Weisz, 1997_cbt_nt",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-12.06,-3.44,17,113,0.294270833333333,0.166770833333333,0.222708333333333,0.116145833333333,0.168645833333333,0.113125,0.186875,0.113854166666667,4.0025,1.9710601525575,"Weisz, 1997"
"120",NA,122,"Weisz, 2009","2009","cbt","cau",1,"cbt","cau","cdi","cdi",5,"self-report",10.88,7.91,32,11.29,7.93,25,8,6.32,25,8.47,8.44,19,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12,10,0.375,0.4,0.48,0.526315789473684,NA,NA,NA,NA,115,56,NA,NA,NA,"n",NA,"us",NA,NA,NA,NA,NA,11.77,2.14,NA,NA,"mood",NA,NA,NA,-0.404778636683064,-0.344532681734881,"Weisz, 2009_cbt_cau",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-2.88,-2.82,0,54,0.201481481481481,0.146481481481481,0.209074074074074,0.146851851851852,0.148148148148148,0.117037037037037,0.156851851851852,0.156296296296296,1.3983036597964,1.586,"Weisz, 2009"
"121",NA,124,"Wood, 1996","1996","cbt","other ctr",1,"cbt","relaxing training","mfq","mfq",7,"parent_report",25.8,9.8,24,28.7,11.6,24,14.9,10.4,24,19.8,13.3,24,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,15,0.708333333333333,0.625,0.708333333333333,0.625,NA,NA,NA,NA,117,69,NA,NA,NA,"n",NA,"uk",NA,13.8,1.7,14.6,1.6,NA,NA,NA,NA,"mood",NA,NA,NA,-1.07920792079208,-0.714859437751004,"Wood, 1996_cbt_relaxing training",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-10.9,-8.9,0,66,0.390909090909091,0.148484848484848,0.434848484848485,0.175757575757576,0.225757575757576,0.157575757575758,0.3,0.201515151515152,2.00041662327293,2.36784008469041,"Wood, 1996"
"122",NA,125,"Young, 2006","2005","ipt","other ctr",1,"ipt","school counseling","ces-d","ces_d",11,"self-report",24.1,6.9,27,27.4,6.6,14,6.4,4.8,27,17.4,10.5,14,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,24,7,0.888888888888889,0.5,0.888888888888889,0.5,NA,NA,NA,NA,118,85,24,5,NA,"n",NA,"us",NA,13.5,1.3,13.1,1.1,13.4,1.2,NA,NA,"cut",NA,NA,NA,-3.02564102564103,-1.16959064327485,"Young, 2006_ipt_school counseling",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-17.7,-10,0,60,0.401666666666667,0.115,0.456666666666667,0.11,0.106666666666667,0.08,0.29,0.175,1.32790561913614,1.763924196622,"Young, 2006"
"123",NA,127,"Young, 2010","2010","ipt","cau",1,"Interpersonal Psychotherapy-Adolescent Skills Training (IPT-AST)","school counseling","cdrs-r","cdrs",1,"clinician",NA,NA,NA,NA,NA,NA,NA,NA,36,NA,NA,21,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,120,59,NA,NA,NA,"n",NA,"us",NA,14.57,0.68,14.52,0.87,14.51,0.76,NA,NA,"cut",NA,NA,NA,NA,NA,"Young, 2010_Interpersonal Psychotherapy-Adolescent Skills Training (IPT-AST)_school counseling",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,17,113,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Young, 2010"
"124",NA,128,"Young, 2016","2016","ipt","other ctr",1,"Interpersonal Psychotherapy-Adolescent Skills Training (IPT-AST)","group counselling","ces-d","ces_d",11,"self-report",15.51,8.52,95,15.07,8.65,91,11.12,8.57,93,12.62,9.28,90,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,29,29,0.305263157894737,0.318681318681319,0.311827956989247,0.322222222222222,NA,NA,NA,NA,121,67,38,27,NA,"n",NA,"us",NA,13.56,1.28,13.42,1.18,14.01,1.22,NA,NA,"cut",NA,NA,NA,-0.513750731421884,-0.273284997211378,"Young, 2016_Interpersonal Psychotherapy-Adolescent Skills Training (IPT-AST)_group counselling",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-4.39,-2.45,0,60,0.2585,0.142,0.251166666666667,0.144166666666667,0.185333333333333,0.142833333333333,0.210333333333333,0.154666666666667,0.874133555976551,0.906766383764459,"Young, 2016"
"125",NA,129,"Yu, 2002","2002","cbt","cau",1,"cbt","nt","cdi","cdi",5,"self-report",17.44,9.47,104,16.72,9.29,116,13.64,9.01,101,16.02,10.16,114,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,30,34,0.288461538461538,0.293103448275862,0.297029702970297,0.298245614035088,NA,NA,NA,NA,122,45,30,26,NA,"n",NA,"eas",NA,11.71,1.71,11.99,1.67,11.8,1.69,NA,NA,"cut",NA,NA,NA,-0.411255411255411,-0.0719794344473007,"Yu, 2002_cbt_nt",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,-3.8,-0.699999999999999,0,54,0.322962962962963,0.17537037037037,0.30962962962963,0.172037037037037,0.252592592592593,0.166851851851852,0.296666666666667,0.188148148148148,0.928609899879302,0.862554845832406,"Yu, 2002"
